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Abstract 
Toxoplasma gondii is a widespread protozoan parasite of humans, domestic animals, and 
wildlife. In this work including nationwide epidemiological cross-sectional studies and 
descriptive case series studies, T. gondii was confirmed as endemic, common, and 
sometimes fatal in a selection of animal hosts in Finland.  
 
Antibodies against T. gondii were detected in all host species investigated, including hosts 
hunted or raised for human consumption. The samples were screened with a commercial 
direct agglutination test using a conservative cut-off for seropositivity. Specific anti-T. 
gondii IgG antibodies were detected in 9.6% of the 1215 moose (Alces alces), 26.7% of 
the 135 white-tailed deer (Odocoileus virginianus), and 17.6% of the 17 roe deer 
(Capreolus capreolus) examined. Seropositive animals were found in 76.3% of 97 sheep 
farms and 60.0% of 25 wild boar farms, while antibodies were detected in 24.6% of the 
1940 individual sheep (Ovis aries) and 33.0% of the 197 farmed wild boars (Sus scrofa) 
examined. Both of the possible definitive hosts present in Finland had commonly 
encountered the parasite: 48.4% of the 490 domestic cats (Felis catus) and 86.1%, a 
significantly higher proportion, of the 337 Eurasian lynx (Lynx lynx) tested seropositive. 
Raw meat in the diet was a major risk factor (odds ratio 2.0) for the infection in domestic 
cats. Evidence of exposure to T. gondii followed a north-south gradient in several hosts. 
The prevalence data indicate an environment contaminated with oocysts. PCR-confirmed 
T. gondii oocysts were found in one (0.8%) of the fecal samples from domestic cats. None 
of the lynx shed oocysts.  
 
Cats also died of toxoplasmosis; the proportional mortality rate was 3.1% among the 193 
domestic cats examined postmortem. The first local T. gondii isolates (FIN1 and FIN2) 
were obtained from two cats into cell culture. Toxoplasma gondii also caused deaths in 
species considered highly susceptible to clinical toxoplasmosis. The proportional mortality 
rates were 8.1% in 173 European brown hares (Lepus europaeus), 2.7% in 148 mountain 
hares (L. timidus), and 15.8% in a limited number of 19 Eurasian red squirrels (Sciurus 
vulgaris). 
 
Direct genotyping of T. gondii strains was based on analysis of length polymorphism at 
six microsatellite markers (B18, TUB2, TgM-A, W35, B17, and M33); one fingerprinting 
marker (M48) was included for further characterization. Both wild and domestic animals 
were infected with strains belonging to genotype II, which was also the genotype of the 
oocysts shed. Strains of genotype II had caused all 27 fatal cases investigated in detail. 
The observed fatality rates among apparently immunocompetent animals challenge the 
prevailing assumption of nonvirulence of genotype II strains.  
 
Toxoplasma gondii infections represent both a public health issue and a welfare issue for 
its hosts. The parasite thrives in Finland and should not be underestimated. 
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1. Prologue 
 
 
 
The zoonotic protozoan Toxoplasma gondii can kill its host 
but to reach another host it desires the most 
 
To lie dormant in a host and get it eaten by another 
or shed as oocysts to be swallowed by a mother 
 
Alas, unlucky to end up in a human it is 
or in a hare that then dies and is not eaten by that pathologist 
 
perhaps part of the game 
but preventable, so whom to blame? 
 
 
Pikka Jokelainen (2012) 
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2. Review of the literature 
2.1. Toxoplasma gondii, a successful parasite 
Toxoplasma gondii was discovered in 1908 (Nicolle and Manceaux, 1908; Splendore, 
1908) in the tissues of a common gundi (Ctenodactylus gundi), a rodent used for 
Leishmania research at the Pasteur Institute, Tunis, and in a rabbit in Brazil. Nicolle 
named it based on its morphology (toxon = bow) and an error in the identification of the 
host as C. gondi: its correct name would have been T. gundii (Dubey, 2007). 
 
Toxoplasma gondii is a zoonotic protozoan parasite that infects virtually all warm-blooded 
animals, including wildlife, domestic animals, and humans (Montoya and Liesenfeld, 
2004; Dubey, 2010). Host can acquire the infection in numerous ways, and new ways have 
been suggested and confirmed even quite recently. Since its discovery, the parasite has 
been found in various hosts and in the environment worldwide (Dubey, 2010), and its 
DNA retrospectively even in mummies (Khairat et al., 2013).  
 
Toxoplasma gondii has three stages: tachyzoite, bradyzoite, and sporozoite. It is an 
obligatory intracellular parasite of the nucleated cells of its hosts (Sabin and Olitsky, 
1937; Jones et al., 1972; Obornik et al., 2009; Cowper et al., 2012). However, in the 
oocyst form that is originally produced in enterocytes, the parasite can survive for a long 
time outside its host (Yilmaz and Hopkins, 1972; Frenkel and Dubey, 1973; Dubey, 
1998b; Dubey, 2010). The three crescent-shaped stages are all infective, and their 
characteristics have been described in detail (Dubey et al., 1998; Speer et al., 1998; 
Dubey, 2010). In acute toxoplasmosis, rapidly multiplying tachyzoites (2 x 6 µm) 
dominate. They are able to cross the placenta, but if ingested, they are usually destroyed in 
the stomach. Bradyzoites and sporozoites are the infective forms typically acquired by 
ingestion. Hundreds of bradyzoites (1-3 x 5-8.5 µm) are enclosed in tissue cysts in 
chronically infected hosts. Eight sporozoites (2 x 6-8 µm) are present in each sporulated 
oocyst (11 x 13 µm), millions of which are shed into the environment unsporulated by the 
definitive hosts of the parasite.  
 
Toxoplasma gondii appears to be one of the most common and widespread parasites in the 
world. Approximately one third of the human population is infected (Birgisdottir et al., 
2006; Moncada and Montoya, 2012; Flegr, 2013b). However, these estimates overlook 
infections in animal hosts and the environmental reservoir. In both human and animal 
hosts, T. gondii infections often go underdiagnosed, underreported (European Food Safety 
Authority EFSA, 2007), and underestimated. For example, chronic, latent infections in 
humans have been considered harmless, but new evidence suggests associations with 
neurological or psychiatric diseases such as schizophrenia (Torrey et al., 2007; Niebuhr et 
al., 2008; Miman et al., 2010a; Miman et al., 2010b; Pedersen et al., 2011; Kusbeci et al., 
2011; Torrey et al., 2012; Horacek et al., 2012; Webster et al., 2013; Flegr, 2013a).  
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Toxoplasma gondii infections are ever common. In some countries, but not all, the 
prevalence of T. gondii infections in humans has been decreasing (Lappalainen, 1995; 
Kortbeek et al., 2004; Welton and Ades, 2005; Jones et al., 2007; Pappas et al., 2009; 
Villena et al., 2010; Hofhuis et al., 2011; Kooskora et al., 2013). In France, for example, 
the seroprevalence among pregnant women was 84% in the 1960s, 54% in the 1990s, and 
44% in 2003 (Villena et al., 2010). In Tartu, Estonia, the seroprevalence was 61.8% in 
1991-1993 (Pehk, 1994) and 54.9% in 1999-2001 (Birgisdottir et al., 2006), and a recent 
nationwide estimate (56.4%) indicates it is still high (Kooskora et al., 2013). The 
prevalence of T. gondii infections has decreased in some animals, such as pigs, likely due 
to their confinement indoors (Edelhofer, 1994; Dubey et al., 1995; Dubey, 2009b). This 
trend may reverse, however, due to more animal-friendly production systems, as was 
observed in Switzerland (Berger-Schoch et al., 2011). Nevertheless, in the larger picture 
encompassing wildlife, domestic animals, and humans, T. gondii infection appears to have 
remained common (Dubey, 2010). 
2.1.1. Life cycle 
Toxoplasma gondii is transmitted in diverse ways, and its life cycle is often described as 
‘complex’. However, completing the life cycle is not necessary for its existence. 
Toxoplasma gondii reproduces both asexually and sexually, lies dormant in the hosts 
under the control of the hosts’ immune responses, and survives in the environment. 
 
Carnivorism and vertical transmission to unborn offspring were the modes of transmission 
of T. gondii first discovered (Wolf et al., 1939; Weinman and Chandler, 1954; Dubey, 
2010). As recently as only 50 years ago, researchers demonstrated the role of cat feces in 
the life cycle of T. gondii (Hutchison, 1965; Hutchison et al., 1969; Sheffield and Melton, 
1969; Hutchison et al., 1970; Frenkel et al., 1970; Overdulve, 1970; Weiland and Kuhn, 
1970; Witte and Piekarski, 1970; Dubey et al., 1970a; Dubey et al., 1970b; Hutchison et 
al., 1971; Dubey, 2009a). These three modes of transmission are usually cited as the main 
ones; the infection can be congenital, acquired by ingesting tissue cysts, or acquired by 
ingesting oocysts. 
 
However, horizontal transmission of tachyzoite stages is also possible. Transmission 
assumably via bodily fluids has been reported in a herd of reindeer (Rangifer tarandus) in 
Russia (Kolychev et al., 1966; Oksanen and Buxton, 1999; Prestrud et al., 2010) and was 
suspected in squirrel monkeys (Saimiri sciureus) living in captivity (Furuta et al., 2001; 
Carme et al., 2009a). Various other ways of introducing T. gondii infection have also been 
reported, including iatrogenic transmission by organ transplantation or blood transfusion, 
laboratory accidents, and a stab wound from a butcher’s knife (Siegel et al., 1971; Ferre et 
al., 1986; Herwaldt and Juranek, 1993; Herwaldt, 2001; Derouin et al., 2008). Studies 
have suggested and demonstrated venereal transmission in some hosts (Dubey and 
Sharma, 1980; Blewett et al., 1982; Arantes et al., 2009; Santana et al., 2010; Dass et al., 
2011; Wanderley et al., 2013), and T. gondii has been detected in the semen of humans 
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(Disko et al., 1971). The milk of infected animals may contain infective T. gondii 
parasites, and any type of milk is considered a potential source of infection if consumed 
unpasteurized (European Food Safety Authority EFSA, 2007; Dehkordi et al., 2013).  
 
A typical T. gondii life cycle illustration depicts a definitive host and an intermediate host 
(Figure 1), and often humans as noteworthy victims of the spillover of the cycle. A cat 
becomes infected after eating a rodent, and the oocysts shed by the cat are the infection 
source for the rodent. This resembles the simple life cycles of other parasites with 
predator-prey and feco-oral transmission, such as the zoonotic cestode Echinococcus 
multilocularis. This simplification fails to encompass the full complexity of known 
transmission routes, and that the parasite can propagate even in the absence of its 
definitive hosts, Felidae, and definitely without humans, who are usually dead-end hosts. 
 
Figure 1 Simplified life cycle of Toxoplasma gondii showing a felid and a pregnant rodent;  
the feco-oral transmission route from a definitive host to another host, carnivorism, 
and vertical transmission to a fetus (Illustrator: Brian Lassen, 2013). 
 
The sexual reproduction of T. gondii can take place only in the intestines of the definitive 
hosts, and the outcome is the shedding of oocysts in the feces (Hutchison et al., 1969; 
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Frenkel et al., 1970; Dubey et al., 1970a; Dubey et al., 1970b; Dubey, 2009a). From an 
epidemiological perspective, the domestic cat is considered the most important definitive 
host (Dabritz and Conrad, 2010). Cats typically encounter the parasite through 
carnivorism and require only one bradyzoite to become infected and subsequently shed 
millions of oocysts after three to ten days (Dubey, 1998a; Dubey, 2001; Dubey, 2009a; 
Dubey, 2010). The prepatent period, from infection to shedding, is longer after ingesting 
oocysts, suggesting adaptation to infection from tissue cysts in cats (Dubey, 1998a; 
Dubey, 2006; Dubey, 2010). Although the shedding time is limited, with a median of eight 
days yet up to three weeks, the number of oocysts produced can range from 3 to 810 
million (Dubey, 2001; Dabritz and Conrad, 2010). The oocysts sporulate in one to five 
days depending on aeration and temperature (Dubey, 2010). The sporulated oocysts are 
infectious and highly resistant to environmental conditions (Yilmaz and Hopkins, 1972; 
Frenkel and Dubey, 1973; Dubey, 1998b; Dubey, 2010). Most cats shed only after their 
primary infection, but reshedding is possible (Dubey, 1976; Dubey, 1995; Dubey, 2010). 
 
Data from studies from all parts of the world show that the majority of T. gondii infections 
in various host species are subclinical and chronic (Dubey, 2010). The parasites multiply 
asexually in the cells of the hosts, and the immune responses of the hosts keep the 
parasites under control in an almost perfect balance of co-existence (Maubon et al., 2008). 
Hosts carry the infection in their tissues presumably for their lifetime, and the parasites are 
transmitted to new hosts through carnivorism, cannibalism, and scavenging, with different 
hosts eating other hosts and even each other (Weinman and Chandler, 1954; Jones and 
Dubey, 2012). This kind of transmission alone is sufficient for many parasites (e.g. the 
zoonotic nematode Trichinella sp.).  
 
Non-felid hosts harboring T. gondii are often referred to as ‘intermediate hosts’, but they 
are unnecessary for the life cycle of the parasite. At least theoretically, the parasite could 
survive in a host population of only definitive hosts because oocysts are also infective to 
them. In this work, ‘intermediate hosts’ are referred to simply as ‘hosts’. The definitive 
hosts also serve as hosts, as do all the others: the parasite stays in their tissues and is 
infective if ingested by another host. A definitive host may also become infected by eating 
another definitive host harboring the parasite.  
 
The parasite invades and multiplies in a broad spectrum of cell types, but eventually 
encysts in muscle tissue and the CNS (Dubey, 1997; Berenreiterova et al., 2011; Cowper 
et al., 2012). The CNS is a good hiding place from the host’s immune responses and might 
also play a catalyzing role in the life cycle (Flegr, 2013a; Flegr, 2013b). The cycle from 
rodents to cats has been suggested to be enhanced by the parasite manipulating the 
behavior of rodents, as T. gondii infected rats appear to be attracted to the odor of cat urine 
(Berdoy et al., 1995; Berdoy et al., 2000; Webster, 2001; Vyas et al., 2007; House et al., 
2011; Berenreiterova et al., 2011). Moreover, possible parasitic manipulation of mate 
choice that could further favor venereal transmission has been observed in rats: uninfected 
female rats preferred T. gondii infected male rats (Dass et al., 2011). 
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2.1.2. Genetic diversity 
The genus Toxoplasma (Nicolle and Manceaux, 1909) belongs to the phylum 
Apicomplexa (Levine, 1970), class Sporozoasida (Leuckart 1879), sub-class Coccidiasina 
(Leuckart 1879), order Eimeriorina (Leger 1911), family Toxoplasmatidae (Biocca, 1956), 
and has only one species, T. gondii. The genome of T. gondii is about 65 Mb, not much 
larger than that of Neospora caninum, but almost three times that of Plasmodium 
falciparum and seven times that of Cryptosporidium parvum (Khan et al., 2007; Reid et 
al., 2012; TOXO DB Toxoplasma Genomics Resource, 2013).  
 
Toxoplasma gondii is a haploid organism, whereby only the fertilized macrogamete is 
diploid. Fertilization is unnecessary for the parasite’s progeny to have a full genome, as it 
comprises one set of chromosomes. Parthenogenesis appears sufficient, or even likely, for 
the production of oocysts due to the low numbers of microgametes formed compared with 
macrogametes (Ferguson, 2002).  
 
Because T. gondii has no sex chromosomes, the self-fertilization of T. gondii 
macrogametocytes by clonal microgametes of the same strain is not only possible, but is 
apparently common (Ferguson, 2002). Clonality appears to be widespread, but is not a 
major disadvantage: the sexual cycle can be skipped due to the efficient asexual 
reproduction of T. gondii by endodyogeny and dispersal via carnivory (Ferguson, 2002). 
Moreover, the endemic parasites of low genetic and phenotypic variation are likely better 
tolerated by the hosts that co-evolved with them (Ajzenberg et al., 2004; Brown et al., 
2005).  
 
The clonal population structure comprising three closely related clonal lineages 
(genotypes I, II, and III) formed the basis for understanding genetic variation in T. gondii 
and its geographical and clinical implications (Tibayrenc et al., 1991; Sibley and 
Boothroyd, 1992; Howe and Sibley, 1995; Dardé, 1996; Ajzenberg et al., 2004; Dardé et 
al., 2007). Sequence similarity and dimorphic allelic composition among the lineages 
indicate a recent common ancestry; the lineages diverged within the past 10 000 years, and 
their widespread distribution is due to asexual transmission (Grigg et al., 2001; Su et al., 
2003; Khan et al., 2006; Khan et al., 2007). More recently, a fourth clonal lineage was 
described and commonly found in wildlife in North America (Khan et al., 2011).  
 
A highly clonal population structure is possible for T. gondii because it does not need the 
sexual cycle in the definitive hosts (Ferguson, 2002), nor even the definitive hosts at all 
(Howe and Sibley, 1995; Su et al., 2003; Khan et al., 2006). Its clonal population structure 
can be maintained when the definitive hosts are rarely infected simultaneously with more 
than one strain of the parasite (Ajzenberg et al., 2004). The occurrence of cross-
fertilization depends on the prevalence of the infection, the diversity of the strains, and the 
occurrence of mixed infections in the prey animals and meat-producing animals. The 
felids, including domestic cats, are predators that hunt substantial numbers of prey of 
different species (Liberg, 1984; Loss et al., 2013) and may also be fed meat from several 
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animals, which provides opportunities for sexual recombination. In southern Sweden in 
the 1970s, for example, 63% of fecal samples from house cats contained the remains of a 
variety of vertebrate prey (Liberg, 1984). The intake of natural prey by these cats was 
estimated at 66 g/day, one fourth that of feral cats. Predation appears to occur regardless 
of whether cats receive other feed from humans (Liberg, 1984; Loss et al., 2013), and 
large fractions of T. gondii infections in domestic cats have been attributed to hunting prey 
as well as receiving raw meat as part of their diet (Opsteegh et al., 2012). 
 
Recombination does occur, giving rise to genetically divergent strains. Greater diversity 
seems to be associated with greater host diversity (Ajzenberg et al., 2004) and less 
anthropization, or human influence on the environment (Mercier et al., 2011). ‘Atypical’ 
genotypes of the parasite have been linked to severe clinical manifestations in humans, 
especially in South America (De Salvador-Guillouet et al., 2006; Elbez-Rubinstein et al., 
2009; Carme et al., 2009b; Delhaes et al., 2010; Subauste et al., 2011; Demar et al., 2012). 
 
Multilocus typing has revealed more polymorphisms (Ajzenberg, 2010; Minot et al., 
2012). Current molecular typing methods are also able to distinguish closely related 
isolates (Ajzenberg et al., 2010). Three types of methods are in widespread use. 
Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) 
methods are based on variation at and distances between restriction sites: analysis of the 
size of DNA fragments that are produced by amplifying selected DNA sequences and 
digesting them subsequently with restriction enzymes (Howe et al., 1997; Khan et al., 
2005; Dubey et al., 2006; Su et al., 2006; Prestrud et al., 2008). Microsatellite (MS) 
methods are based on analysis of the length polymorphism of microsatellite markers: 
variation in the numbers of short repeat motifs (Ajzenberg et al., 2005; Ajzenberg et al., 
2010). Multilocus sequencing typing (MLST) is a nucleotide sequence-based approach 
that detects further polymorphism, but is costly for screening large sample sets (Ajzenberg 
et al., 2010; Su et al., 2012). Phylogenetic studies of a large dataset of combined results 
obtained with these three methods revealed 138 distinct genotypes, most of which could 
be grouped into 15 haplogroups and further into six major clades (Su et al., 2012). 
Representative strains of each haplogroup are included in a whole genome sequencing 
effort. The study provided new information on the genetic diversity and, to some extent, 
on geographical differences in the distribution of this diversity. Some parts of the world 
remain poorly represented, however: in particular, no strains from Finland, the Baltic 
countries, or Russia were analyzed (Su et al., 2012). 
 
Since the beginning of the molecular typing of T. gondii strains, different genotypes have 
been linked to differences in their virulence in hosts: namely, the outcome of experimental 
inoculation into laboratory mice and the severity of human disease (Sibley and Boothroyd, 
1992; Howe and Sibley, 1995; Dardé, 1996; Dardé et al., 1998; Ajzenberg et al., 2002; 
Ajzenberg, 2006; Dardé et al., 2007; Ajzenberg et al., 2009; Ajzenberg, 2010; Subauste et 
al., 2011; Fekkar et al., 2011; Carneiro et al., 2013). Fewer than ten tachyzoites of a 
virulent genotype I strain can kill a laboratory mouse, while genotypes II and III typically 
cause only chronic infections in mice (Maubon et al., 2008). Atypical genotypes have been 
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associated with severe clinical toxoplasmosis, even in immunocompetent humans 
(Sobanski et al., 2013). Genetic characterization of the T. gondii strains that cause disease 
and death in different host species deepens our understanding of the factors that affect the 
outcome of the infection, especially of the contribution of the characteristics of the 
parasite.  
 
While the association between the T. gondii genotype and clinical outcome has received 
attention in human medical parasitology (Dardé et al., 2007; Ajzenberg, 2010), few similar 
data are available from naturally-acquired infections in non-human animal hosts. The 
clonal genotype II is dominant and endemic in Europe (Aubert et al., 2010; Subauste et al., 
2011; Fekkar et al., 2011; Herrmann et al., 2013) and is associated mainly with mild 
clinical manifestations in immunocompetent humans (Sobanski et al., 2013). Human 
medical doctors appear to be more concerned about the imported atypical strains that 
cause more severe disease (Sobanski et al., 2013). From Europe, however, descriptions are 
available of one domestic cat, one beaver (Castor fiber), and four arctic foxes (Vulpes 
lagopus) that died of infections with genotype II strains without predisposing 
immunodeficiency (Prestrud et al., 2008; Spycher et al., 2011; Herrmann et al., 2013). 
Moreover, material from ovine abortion cases indicated an association of genotype II 
parasites, but not of genotype III parasites, with histopathological lesions consistent with 
toxoplasmosis (Gutierrez et al., 2012). These results are surprising because they contradict 
the assumption that strains belonging to genotype II would cause only mild, chronic 
infections (Dardé et al., 2007; Maubon et al., 2008).  
2.1.3. Limits 
Although the immune responses of the host fight the T. gondii infection, the battle is 
usually lost, and the attack leads to permanent occupation. Resistance is not futile, 
however; the host’s immune response is needed to establish a balanced chronic infection 
that enables the host and the parasite to co-exist (Maubon et al., 2008). With no or an 
insufficient immune response, the parasites profilerate uncontrolled or are reactivated, and 
the infection may become fulminant. Instead of reaching a balanced latency, the host and 
its parasites may die from the resultant overwhelming infection (Maubon et al., 2008).  
 
The infective stages differ in their resistance to external conditions. Tachyzoites are the 
easiest to destroy, and the conditions of the stomach are usually sufficient to kill them 
(Dubey, 2010). Pasteurization or boiling destroys any tachyzoites and bradyzoites present 
in milk. When placed in an optimal freezing medium, T. gondii parasites grown in cell 
culture can be cryopreserved (Dubey, 2010). 
 
The tissue stages of T. gondii including tissue cysts can be killed by temperatures of 67°C 
or higher (Dubey, 2010). Cooking in a microwave oven, salting, curing, and pickling are 
unreliable ways of killing tissue cysts (Lundén and Uggla, 1992; Dubey, 2010). Freezing 
generally appears to kill tissue cysts, at least at -20°C for 54 hours, but the parasite may 
 
 
 
 
21 
survive freezing conditions (Lundén and Uggla, 1992; Dubey, 2010). A Russian study 
reported that T. gondii survived in reindeer meat at -11°C to -56°C for up to 28 days 
(Kolychev, 1969). At 4°C, T. gondii tissue cysts may remain viable for more than two 
months (Jacobs et al., 1960). Rotting of the tissue around the cysts appears to have little 
effect, as an isolate was obtained even from a bird largely consumed by maggots (Work et 
al., 2000).  
 
The sporulated oocysts are highly resistant to environmental conditions (Yilmaz and 
Hopkins, 1972; Frenkel and Dubey, 1973; Dubey, 1998b; Dubey, 2010). In natural 
conditions outdoors, in shade and exposed to a temperature range of 5.5-35.5°C, they 
survived in cat feces for 2.5 months uncovered, and almost for a year covered (Yilmaz and 
Hopkins, 1972). Experimental studies have shown that oocysts remain infective for up to 
54 months at 4°C and for four weeks frozen at -21°C, but were killed in one minute at 
60°C (Frenkel and Dubey, 1973; Dubey, 1998b).  
 
The effect of common disinfectants on oocysts is weak; the available reagents have no 
effect or require an impractically long contact time to be effective (Wainwright et al., 
2007b; Dubey, 2010). Several pharmaceutical compounds have proved anti-toxoplasmic 
(Dubey, 2010). The aims of treatment are to control active infection and to prevent its 
transplacental transmission (Moncada and Montoya, 2012). 
 
Additional studies on the survival of T. gondii are needed to evaluate available preventive 
measures and treatment options as well as to design new ones. One limitation common to 
many available studies is that they used few different strains of the parasite. Local strains 
might be more adapted to local conditions (Kolychev, 1969). 
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2.2. Toxoplasma gondii in its hosts 
For T. gondii, any nucleated cell in a warm-blooded animal or in favorable in vitro 
circumstances is a good home. In a host, immunity should restrict the parasite to a chronic 
state of infection for mutual longer life (Maubon et al., 2008). A good host is one that 
becomes infected with a low infection dose and has several means of acquiring the 
infection, but is little affected by it. A host that, after infection, is likely to be eaten by 
another host ensures the parasite a longer life than just one host lifetime. 
 
Toxoplasmosis is an infectious disease and upon infection, the parasite invades the tissues 
of its host. This should be distinguished from the contamination of food with infective 
stages of the parasite. Sometimes T. gondii infections are referred to as ‘contamination’, 
especially meat of infected animals as ‘contaminated meat’ (e.g. Halos et al., 2010; Pastiu 
et al., 2013; Centers for Disease Control and Prevention, 2013). 
 
Most hosts assist in propagating the parasite to new hosts. Felids may contribute to the 
environmental oocyst reservoir by shedding, and some also support the survival of the 
oocysts with their habit of covering their freshly deposited feces with soil. Soil coverage 
likely extends the oocysts’ survival (Yilmaz and Hopkins, 1972). The numbers of oocysts 
shed are high, making the felids highly amplifying hosts. Migrating and traveling hosts 
introduce the parasite to new areas (Prestrud, 2008). Chronically infected hosts serve as an 
amplifying reservoir: enrichment by asexual reproduction and spreading to different 
tissues enables the subsequent infection of even several new hosts via carnivorism and 
scavenging (Weinman and Chandler, 1954). The associations of chronic infection with 
changes in behavior, memory, and neurologic disorders (Berdoy et al., 1995; Berdoy et al., 
2000; Webster, 2001; Vyas et al., 2007; Torrey et al., 2007; Pedersen et al., 2011; Dass et 
al., 2011; House et al., 2011; Berenreiterova et al., 2011; Pedersen et al., 2012; Torrey et 
al., 2012; Webster et al., 2013; Flegr, 2013a) are intriguing, especially as some of them 
appear to benefit the parasite in infecting new hosts.  
 
It is most often detrimental for a parasite to kill its host. The stage of T. gondii dominating 
in acute fulminant toxoplasmosis is the tachyzoite, the most delicate and the least infective 
stage by ingestion to scavengers; killing the host outright usually results in the death of 
those tachyzoites as well (Maubon et al., 2008).  
 
The majority of T. gondii infections in most host species are subclinical or asymptomatic, 
and chronic (Dubey, 2010); the parasite remains dormant in the tissues of the host until 
reactivation or until it is eaten by another host. Thus, most hosts survive the infection and 
acquire life-long immunity, while likely harboring the parasite in their tissues for the rest 
of their lives (Dubey, 2010). The immune response of the host is important for the parasite 
as well; without it, the infection would become fulminant (Maubon et al., 2008). Chronic, 
latent T. gondii infections can generally be detected indirectly by screening for the 
presence of specific antibodies produced against the parasite (Dubey, 2010). In most host 
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species, chronic infections are common: the seroprevalence numbers are high, and the 
incidence of clinical toxoplasmosis is low (Dubey, 2010).  
 
Using serology to evaluate the prevalence of T. gondii infection in the hosts has its 
limitations. First, serology is an indirect method that detects only the humoral immune 
response against the pathogen: seronegative animals have been found to be infected or 
have tested positive for the parasite’s DNA (Dubey et al., 1995; Opsteegh et al., 2011b). 
Serology cannot detect cross contamination, which can be regarded as a limitation of its 
use in monitoring at slaughterhouses. On the other hand, the immune response is systemic, 
whereas direct detection methods, such as PCR or bioassay, applied on small samples may 
miss a low or unevenly distributed parasite burden. Second, screening usually only targets 
IgG antibodies, methods are rarely validated or even suitable for all hosts, and cut-offs for 
seropositivity are often somewhat arbitrary (Dubey, 2010). Third, the assumption of the 
persistence of antibodies has been recently questioned in some hosts species (Opsteegh et 
al., 2011a; Fernandez-Aguilar et al., 2013). Regardless, advancements in serology have 
greatly changed our understanding of the spread, duration, origin, and dynamics of T. 
gondii infections (Sabin and Feldman, 1948; Fulton and Turk, 1959; Hedman et al., 1989; 
Lappalainen et al., 1993; Hill et al., 2011). 
 
As rare exceptions, congenital toxoplasmosis has been described in previously 
seropositive mothers, possibly after infection with another parasite strain (Delhaes et al., 
2010) or due to reactivation of a chronic infection (Andrade et al., 2010). The immunity of 
the host that is measurable by serology cannot thus be regarded as fully protective. This is 
in contrast to the common assumption behind screening programs for pregnant women. 
 
Pregnant hosts appear to be relevant for T. gondii. Vertical transmission to unborn 
offspring can prove fatal or cause various clinical manifestations of congenital 
toxoplasmosis in them, but it is also a means of transmission for the parasite (Duncanson 
et al., 2001; Williams et al., 2005; Hide et al., 2007; Hide et al., 2009). At least in some 
hosts, including some strains of mice, sheep, Pallas cats, sand cats, and – at least in rare 
cases – humans, vertical transmission appears not to be limited to primary infection, but 
also occur during chronic infections, and even repeatedly (Beverley, 1959; Brown et al., 
2005; Williams et al., 2005; Pas and Dubey, 2008, Andrade et al., 2010).  
 
Severe forms of congenital toxoplasmosis are probably the most feared clinical 
manifestations of Toxoplasma gondii infection in humans, but the parasite can also cause a 
variety of clinical signs and symptoms after a postnatally acquired infection, and even 
prove fatal to its host (Montoya and Liesenfeld, 2004; McAllister, 2005; Demar et al., 
2007; Dubey, 2010; Moncada and Montoya, 2012). In immunocompetent humans, the 
infection is asymptomatic in most cases or manifests as cervical or occipital 
lymphadenopathy that can last for months (Montoya and Liesenfeld, 2004). Even 
apparently asymptomatic or mild infections cannot be considered harmless (McAllister, 
2005; Flegr, 2013b). Severe, generalized forms of the disease can also occur in the 
immunocompetent (Dardé et al., 1998; Montoya and Liesenfeld, 2004; McAllister, 2005; 
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Demar et al., 2007; Demar et al., 2012; Sobanski et al., 2013). Ocular toxoplasmosis, 
toxoplasmic chorioretinitis, was previously interpreted as a late manifestation of 
congenitally acquired infection, but can be also the clinical outcome of an acquired 
infection (Montoya and Liesenfeld, 2004; Subauste et al., 2011; Vasconcelos-Santos, 
2012). Immunocompromised humans are at risk for toxoplasmic encephalitis, pneumonia, 
and other severe forms of toxoplasmosis (Lappalainen et al., 1998; Montoya and 
Liesenfeld, 2004; Edvinsson et al., 2009; Ajzenberg et al., 2009). 
 
Both host and parasite factors affect the outcome of T. gondii infection, and the 
environment may also have an effect (Dardé et al., 2007; Maubon et al., 2008; Subauste et 
al., 2011). The immunostatus of the host is a major factor: T. gondii has been an important 
cause of morbidity and mortality in AIDS patients, especially before the introduction of 
highly active antiretroviral therapy (Luft and Remington, 1992; Nissapatorn, 2009), and 
iatrogenic immunosuppression may reactivate a latent infection in an organ recipient 
(Lappalainen et al., 1998).  
 
The clinical picture of toxoplasmosis in animal hosts can resemble those described in 
humans (Dubey, 2010). Most infections remain subclinical, which does not necessarily 
mean that they are asymptomatic. Clinical signs are something others observe, whereas 
symptoms are subjective and can go unnoticed, yet still affect the welfare of the animal. 
Clinical signs are largely unspecific, and virtually all imaginable clinical signs have been 
listed among the possible manifestations in, for example, feline toxoplasmosis (Dubey and 
Lappin, 2006). Vertical transmission of the infection has been described in numerous 
hosts (Dubey et al., 2008; Hide et al., 2009; Dubey, 2010) and is of major veterinary 
importance, especially in sheep and goats (Duncanson et al., 2001; Williams et al., 2005; 
Hide et al., 2007; Hide et al., 2009; Dubey, 2009c; Dubey, 2010). Generalized, fatal 
infections have also been described in many host species (Dubey, 2010; Spycher et al., 
2011). Reports of treatment success in confirmed severe clinical toxoplasmosis cases are 
few compared with the number of reported fatalities (Dubey, 2010).  
 
Some host species appear to be highly susceptible to severe clinical toxoplasmosis. These 
species include European brown hares, mountain hares, Eurasian red squirrels, Australian 
marsupials, New World monkeys, Pallas cats, and sand cats (Rodhain, 1950; Christiansen 
and Siim, 1951; Riemann et al., 1974; Gustafsson, 1997; Ketz-Riley et al., 2003; Brown et 
al., 2005; Pas and Dubey, 2008; Dubey, 2010). The specific reasons behind such 
susceptibility remain largely unknown, but appear to include host genetics (Maubon et al., 
2008; Subauste et al., 2011), differences in mounting an appropriate immune response 
(Gustafsson et al., 1997b; Ketz-Riley et al., 2003), and possibly a lack of co-evolution 
(Brown et al., 2005). Interestingly, in the hares living in Scandinavia, researchers have 
long observed that mortality due to toxoplasmosis is highest in the winters (Hülphers et 
al., 1947; Christiansen and Siim, 1951). Many other factors such as the infective stage of 
the parasite causing the infection, the infection dose, the infection route, and especially the 
characteristics of the T. gondii strains causing the severe and fatal infections have seen 
little investigation (Prestrud et al., 2008; Spycher et al., 2011; Herrmann et al., 2013). 
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Genetic characterization of the T. gondii strains that infect different hosts in different parts 
of the world deepens our understanding of the molecular epidemiology of this parasite in 
its hosts and may reveal possible separate and overlapping cycles, reservoirs and 
spillovers (Dardé et al., 2007).  
2.3. Toxoplasma gondii in the environment 
Toxoplasma gondii has an environmental reservoir of durable oocysts. The parasite is 
present in soil and water, and the sporulated oocysts can survive the temperature ranges 
and other conditions of most locations (Yilmaz and Hopkins, 1972; Frenkel and Dubey, 
1973; Dubey, 1998b; Dubey, 2010).  
 
The environmental reservoir of oocysts forms an important source of T. gondii infection, 
especially for herbivorous hosts that are unlikely to eat other hosts. Such hosts include 
domestic animals raised and game animals hunted for human consumption. Reducing the 
environmental oocyst burden is considered the most effective way to reduce T. gondii 
infections in farm animals (Kijlstra and Jongert, 2008). Of the preventive measures 
recommended (Dubey, 1996; Tenter et al., 2000; Lehmann et al., 2003; Kijlstra and 
Jongert, 2009; Dubey, 2009b), the most feasible ones are keeping sties, pastures, feed, and 
water uncontaminated by feline feces, alongside rodent control, offal hygiene, and 
securing the interface with wildlife. The sporulated oocysts are environmentally resistant 
(Yilmaz and Hopkins, 1972; Frenkel and Dubey, 1973; Dubey, 2010) and may spread into 
the environment from the location where the feces were deposited (McAllister, 2005; 
Dabritz and Conrad, 2010). Having no cat on the farm is often mentioned as a preventive 
measure for the farm level, whereas preventing the infections of the cats living on the 
farm, using currently available preventive measure options, has received less emphasis 
(Kijlstra and Jongert, 2009). Preventing the infection of felids, especially of domestic cats, 
would likely have a detectable effect on reducing oocysts in the environment, especially in 
areas with no feral cats or wild felids (McAllister, 2005).  
 
Due to the environmental oocyst reservoir, T. gondii can also be a waterborne pathogen 
(Dubey, 2004; Jones and Dubey, 2010). Moreover, coastal surface water runoff into the 
oceans has been linked to deaths in southern sea otters (Enhydra lutris nereis) (Miller et 
al., 2002; Kreuder et al., 2003; Miller et al., 2004; Miller et al., 2008; Shapiro et al., 2012). 
Considering that conventional sewage and water treatments cannot destroy the sporulated 
oocysts, which can survive for two years in 4°C sea water (Wainwright et al., 2007a; 
Wainwright et al., 2007b; Lindsay and Dubey, 2009), our blue planet is widely 
contaminated with infective forms of the parasite (McAllister, 2005; Dabritz and Conrad, 
2010).  
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2.4. Toxoplasma gondii as a zoonotic pathogen 
Toxoplasma gondii is a zoonotic parasite: infections from non-human animals to humans 
and vice versa are possible (Wolf et al., 1939). Humans are probably unimportant hosts 
from the perspective of the parasite, but human infections are a major reason for the 
extensive research efforts around this parasite. Due to its numerous infection routes, T. 
gondii infections belong at least to the overlapping lists of foodborne, waterborne, soil-
transmitted, milk-transmitted, cat litter box -derived, iatrogenic, bloodborne, occupational, 
opportunistic, and zoonotic infections (Siegel et al., 1971; Cook et al., 2000; Herwaldt, 
2001; Weese et al., 2002; Dubey, 2004; Derouin et al., 2008; Dubey, 2010). Eating 
undercooked meat of infected animals has been identified as the main risk factor for 
human infection (Cook et al., 2000). 
 
The various manifestations of toxoplasmosis influence the quality of life of those affected 
(Kupila et al., 1999; McAllister, 2005; de-la-Torre et al., 2011). At worst, toxoplasmosis 
can be devastating and even fatal. Moreover, even mild chronic T. gondii infections cannot 
be considered harmless (McAllister, 2005; Torrey et al., 2007; Flegr et al., 2009; Arling et 
al., 2009; Pedersen et al., 2011; Pedersen et al., 2012; Kankova et al., 2012; Thomas et al., 
2012; Torrey et al., 2012; Flegr, 2013b). 
 
In the 1990s in Finland, the lifetime cost per case of congenital toxoplasmosis was 
estimated to be USD 0.8 million, ranging from USD 0.01 million for a subclinically 
infected to USD 1.5 million for a severely affected child (Lappalainen et al., 1995b). 
Estimates of the annual costs of congenital toxoplasmosis were USD 128 per pregnancy; 
lowering these costs, and thus saving USD 2.1 million per year, might have been achieved 
by launching a screening program (Lappalainen et al., 1995b).  
 
The disease burden caused by pathogens that differ in the incidence of infections and the 
severity of their outcomes can be evaluated and compared by expressing them in 
disability-adjusted life years, or DALYs (Murray, 1994; Murray and Lopez, 1996; Murray 
and Acharya, 1997). Life years lost, time lived with a disability, and the severity of the 
disability are all taken into account. Calculations of the DALYs of T. gondii infections 
have emphasized that T. gondii belongs among the most important foodborne pathogens, 
together with Salmonella spp. and Campylobacter spp. (Kemmeren et al., 2006; Havelaar 
et al., 2007; Kortbeek et al., 2009; Havelaar et al., 2012). On the population level, the total 
disease burden of combined congenital and acquired toxoplasmosis (3620 DALYs per 
year) was higher than the burden of any of the other 13 pathogens investigated, surpassing 
even that of Campylobacter spp. and Salmonella spp. (Havelaar et al., 2012). On an 
individual level, the disease burden of congenital toxoplasmosis ranked second, after 
listeriosis (Havelaar et al., 2012). 
 
Another frequently used unit of measure is quality-adjusted life year, or QALY, which 
emphasize the time lived in good health. In the USA, T. gondii infections cost USD 3 
billion and account for 11 000 QALYs lost every year (Hoffmann et al., 2012). These 
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numbers place T. gondii among the top five most important pathogens (Hoffmann et al., 
2012; Batz et al., 2012). Moreover, when comparing foodborne illnesses by the mortality 
they cause, T. gondii infections ranked second after Salmonella spp. (Scallan et al., 2011). 
 
The disease burden and losses caused by a zoonotic pathogen such as T. gondii are not 
limited to humans. The prevention of T. gondii infections in its animal hosts carries 
implications not only for food safety and public health (Sacks et al., 1983; McDonald et 
al., 1990; Cook et al., 2000; Ross et al., 2001; Kijlstra and Jongert, 2008; Kijlstra and 
Jongert, 2009; Veterinærinstituttet, 2009), but is also an animal health care measure that 
ensures the welfare of the animals and prevents the occurrence of possible clinical disease 
in them. The clinical signs reported from domestic pigs during T. gondii outbreaks include 
high fever, anorexia, dyspnea, vomiting, weakness, recumbency, abortions, and death 
(Weissenbock and Dubey, 1993; Kim et al., 2009; Dubey, 2009b). The clinical signs 
observed after experimental infections in sheep include not only abortions and dead lambs, 
which are known to cause considerable economic loss to sheep husbandry, but also 
invariably fever and sometimes other signs, such as respiratory distress (Dubey, 2009c). 
These clinical signs are surely a welfare matter for the individuals affected. In addition to 
animals intended for human consumption, the animal welfare aspect is also relevant for 
pet animals. Domestic cats obviously contaminate the environment with oocysts (Dabritz 
and Conrad, 2010), but may also fall ill themselves and die from the infection (Henriksen 
et al., 1994; Dubey, 2010): they therefore merit better protection against the infection 
(Opsteegh et al., 2012). 
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2.5. Toxoplasma gondii in Finland 
Few studies of T. gondii infections in Finland are available, and most of them date to the 
1990s. Estimates of T. gondii seroprevalences have been reported in humans and several 
animal host species (Table 1).  
 
Antibodies against T. gondii have been reported in foxes, brown hares and mountain hares 
(Valtonen and Andersson, 1968), lynx (Oksanen and Lindgren, 1995), semi-domesticated 
reindeer (Oksanen et al., 1996; Oksanen et al., 1997), domestic pigs (Hirvelä-Koski, 
1992), horses (Nieminen, 1993), cats (Näreaho, 1995; Näreaho et al., 1995), and the 
animals of the Helsinki Zoo (Saarhelo, 1998); the latter three were projects of 
undergraduate veterinary students.  
 
In humans, overall seroprevalence was 28.7% in a study among farmers and 
slaughterhouse workers (Seuri and Koskela, 1992) and 20.3% among pregnant women in 
southern Finland (Lappalainen et al., 1992). An earlier study reported up to 66.7% of 
pedigree cat owners testing seropositive, a high figure compared with the 33.3% of the 
control group, even if having a cat in the family was not a risk factor for the infection 
(Ulmanen and Leinikki, 1975). The most recent estimate available suggests a continuous 
decrease in seroprevalence, which among participants of a national veterinary congress 
was 16.3% (Jokelainen et al., 2010).  
 
In the 2000s, between 34 and 48 human toxoplasmosis cases have been reported annually 
(Zoonoosikeskus/Valtakunnallinen tartuntatautirekisteri, 2013). Severe, clinical cases have 
been described in Finland in humans (Koskiniemi et al., 1989; Lappalainen et al., 1995a; 
Lappalainen et al., 1998; Kupila et al., 1999) and dogs (Hollmén et al., 1995). The dogs 
were a litter of Newfoundland puppies with severe neurological signs, hydrocephalus 
revealed with diagnostic imaging, and periventricular calcifications detected postmortem. 
The diagnosis was confirmed with PCR targeting the B1 gene (Burg et al., 1989).  
 
Fatal toxoplasmosis is among the frequently diagnosed infectious causes of death for 
many animal species in Finland, but exact numbers of cases are available only from the 
1960s for nine species (Valtonen and Andersson, 1968). The proportional mortality rates 
could not be calculated because the total numbers of animals examined were not specified. 
The species in which toxoplasmosis was diagnosed were brown hare, mountain hare, dog, 
cat, pig, fox, squirrel, capercaillie (Tetrao urogallus), and black grouse (Lyrurus tetrix). 
These diagnoses were not confirmed with specific methods. Toxoplasmosis in pet animals 
and abortions in sheep due to T. gondii have been diagnosed sporadically at Finnish Food 
Safety Authority Evira (Finnish Food Safety Authority Evira, 2010; Finnish Food Safety 
Authority Evira, 2012a; Finnish Food Safety Authority Evira, 2012b). Toxoplasmosis is a 
notifiable disease in all animals except hares, rabbits and rodents 
(Eläinlääkintölainsäädäntö, 1995), but the official data available appear not to represent 
the true incidence (European Food Safety Authority EFSA et al., 2012). 
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The T. gondii strains causing the infections in the various hosts were characterized no 
further. The genotypes of T. gondii circulating in Finland are unknown.  
 
An experimental study of two reindeer resulted in the death of one of them on day nine; 
the clinical disease responded to therapy in the other (Oksanen et al., 1996). The latter had 
high antibody titers, lived for nearly two years after inoculation and died in a brown bear 
attack. Experimental feeding of meat from infected reindeer to a seronegative lynx 
induced seroconversion, but no detectable oocyst shedding (Oksanen et al., 1997). 
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Toxoplasma gondii appears to be largely unchallenged in Finland. The infections are not 
monitored at slaughterhouses (Eläinlääkintölainsäädäntö, 2011), and the health care 
programs of farm animals appear to place little emphasis on preventing them (Eläintautien 
torjuntayhdistys ETT ry, 2013; Finnish Food Safety Authority Evira, 2013b). No vaccine 
is commercially available against toxoplasmosis for any host species, and no 
pharmaceutical product is specifically registered for its treatment in any animal host 
species (Kariaho, 2013). Pregnant women receive some advice on how to avoid T. gondii 
infection (National Institute for Health and Welfare, 2013a; National Institute for Health 
and Welfare, 2013b), and toxoplasmosis is acknowledged as an occupational hazard for 
veterinarians during pregnancy (Reijula et al., 2005), but no systematic screening of 
pregnant women has been launched despite the calculations and recommendations of the 
1990s (Lappalainen et al., 1995b). Toxoplasmosis is missing from the list of zoonoses of 
the National Institute for Health and Welfare (National Institute for Health and Welfare, 
2013c). Toxoplasma gondii was not even mentioned in the risk analysis report on raw milk 
produced in Finland (Perkiömäki et al., 2012), nor included on the list of 11 main zoonotic 
pathogens in the national zoonoses strategy for 2013-2017 (Ministry of Agriculture and 
Forestry and Ministry of Social Affairs and Health, 2013). 
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3. Aims of the study 
The general aim of this study was to clarify the molecular epidemiology of T. gondii in 
Finland, especially for possible evidence of separate domestic and sylvatic cycles. The 
specific aims were: 
 
1. to estimate the prevalence of specific anti-Toxoplasma gondii IgG antibodies 
(I, II, III, V, VI) and the incidence of naturally acquired fatal toxoplasmosis (III, 
IV, V, VI) in selected wild and domestic host species, as well as the percentage of 
possible definitive hosts shedding T. gondii oocysts (V, VI) in Finland 
 
2. to determine and evaluate risk factors for T. gondii infections in these hosts 
(I, II, III, IV, V, VI) 
 
3. to investigate the toxoplasmosis cases in detail from the point of view of 
both the host, by describing the pathological changes, and the parasite, by 
genetically characterizing the causative T. gondii strains (III, IV, V) in order to 
unveil possible associations between the genotype of the parasites and the outcome 
of the infections. 
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4. Materials and methods 
4.1. Study design and ethics 
The studies were nationwide epidemiological cross-sectional studies (I, II, III, V, VI) and 
descriptive case series studies (III, IV, V) of naturally-acquired T. gondii infections in 
non-human animal hosts. The study area was Finland, located in northeastern Europe 
between the 60th and 70th parallels. The studies were carried out in 2008-2012, but also 
included retrospective material (II, III, IV, VI).  
 
No animal was killed and no non-human blood was drawn solely for these studies. The 
blood samples from sheep and wild boars were taken primarily for another disease 
surveillance program and project (I, II). The blood samples from purebred pet cats were 
sampled with the owners’ consent for a feline DNA bank and for parasitological and 
virological research use (ethical permit ESAVI-2010-0392/Ym-23), and the blood samples 
from shelter cats were leftover routine diagnostic samples taken by shelter veterinarians 
(V). Other samples were taken after the animals were killed either by legal hunting (I, III, 
VI) or slaughtering (II), or had either died (III, IV, V) or had been euthanized by a 
veterinarian (V) and subsequently submitted for postmortem examination.  
 
No bioassays in laboratory animals were used in these studies, and the parasite isolation 
was performed into cell cultures.  
 
The persons whose samples were used in the blind experiment to evaluate the effect of 
hemolysis on the serology method provided their oral informed consent. All information 
obtained from the hunters, farmers, and cat owners in the questionnaires (I, II, V, VI) are 
stored securely and treated confidentially. The samples are stored coded.  
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4.2. Hosts included in the studies 
Toxoplasma gondii has a wide variety of host species, including practically all warm-
blooded animals (Dubey, 2010). The inclusion of hosts for these studies was based on 
relevance from several viewpoints, including assumed importance for the success of the 
parasite in Finland, potential risks for human infections, as well as veterinary clinical 
relevance and animal welfare issues. These studies included both wild, free-ranging 
animals and domestic animals.  
4.2.1. Hosts intended for human consumption 
The prevalence of chronic T. gondii infections was investigated in selected hosts that were 
either raised or hunted for human consumption. Moose (Alces alces), white-tailed deer 
(Odocoileus virginianus) and roe deer (Capreolus capreolus) are free-ranging wild 
ruminants that are important game animals (I). In 2005-2010, the annual game bag was 
57 097-75 587 moose, 21 900-25 694 white-tailed deer, and 3165-4182 roe deer (Finnish 
Game and Fisheries Research Institute, 2013). Harvested moose meat comprises 75% of 
the entire game meat yield of 10 million kilograms (Finnish Game and Fisheries Research 
Institute, 2009). Sheep (Ovis aries) was selected as a domestic ruminant host (I), and 
farmed wild boar (Sus scrofa) falls in-between: a game animal farmed for slaughter (II). 
The domestic sheep population is 130 000, and the meat production is 95 000 kg per year 
(Agricultural Statistics, 2013a; Agricultural Statistics, 2013b). The annual game bag of 
free-ranging wild boars is 75-110 (Finnish Game and Fisheries Research Institute, 2013), 
whereas 150-466 farmed wild boars are slaughtered for meat each year (Finnish Food 
Safety Authority Evira, 2013a). 
 
The European brown hare (Lepus europaeus) and mountain hare (Lepus timidus) were 
included mainly due to their suggested high susceptibility to fatal toxoplasmosis, but they 
are also important game animals hunted for their meat (III; 4.2.2), and Eurasian lynx (Lynx 
lynx) as a potential definitive host (VI; 4.2.3), but their meat is also occasionally prepared 
as food in Finland. 
 
All the moose and deer were hunted, and all the sheep and wild boars were raised for 
human consumption (I, II). All the wild boars were slaughtered, passed meat inspection, 
and used for human consumption (II).  
4.2.2. Hosts suggested as highly susceptible to severe clinical toxoplasmosis 
Fatal cases of toxoplasmosis among European brown hares, mountain hares (III), and 
Eurasian red squirrels (Sciurus vulgaris) (IV) were selected for investigation in detail, as 
these host species have previously been proposed as exceptionally susceptible to severe 
clinical toxoplasmosis (Rodhain, 1950; Christiansen and Siim, 1951; Gustafsson, 1997). 
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In 2005-2010, the annual game bag was 159 200-209 900 mountain hares, 65 900-89 000 
brown hares, and 4400-10 200 squirrels (Finnish Game and Fisheries Research Institute, 
2013). 
4.2.3. Possible definitive hosts 
Both felids living in Finland, the domestic cat (Felis catus) (V) and the Eurasian lynx 
(VI), were investigated for various aspects of toxoplasmosis and for their role in the 
epidemiology of T. gondii infections.  
 
The domestic cat population in Finland comprises approximately 800 000 pet cats. Pet 
cats are legally permitted to roam unleashed (Public Order Act, 2003). Feral cats are 
practically non-existent.  
 
The Eurasian lynx is the only wild felid living in Fennoscandia. The lynx population has 
doubled in the past decade and currently numbers about 2340-2610 adult lynx (Finnish 
Game and Fisheries Research Institute, 2008). Although protected (Council Directive, 
1992), lynx are hunted with special permits granted by the Ministry of Agriculture and 
Forestry.  
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4.3. Sampling and sample storage 
4.3.1. Sample size calculations 
The sample sizes for the seroprevalence studies were calculated beforehand to obtain 
estimates at an acceptable precision (L = 0.03-0.05) and type I error rate (5%; Z = 1.96) 
(Dohoo et al., 2003; Dean et al., 2013). The calculations were based on expected 
seroprevalences of 10-20% for moose, 30-40% for deer, 10-45% for sheep (I), 10% for 
farmed wild boars (II), < 5% for hares (III), 45% for domestic cats (V), and 70-75% for 
lynx (VI). The sample size calculation for sheep (I) was revised with an intra-cluster 
correlation coefficient (0.2) and a sampling plan of 20 samples per flock to account for the 
clustering of sheep into flocks where they are more likely to be similarly exposed to T. 
gondii (Dohoo et al., 2003). The overall sample size for moose (I) was tripled to allow for 
comparison between data from different geographical areas. The target sample sizes were 
700 moose, 350 white-tailed deer and 350 roe deer, 1920 sheep (I), 150 farmed wild boars 
(II), 100 brown hares and 100 mountain hares (III), 400 cats (V), and 300 lynx (VI).  
 
The expected proportional mortality rates used in sample size planning (Dohoo et al., 
2003; Dean et al., 2013) were 10% for European brown hares (III), 5% for mountain hares 
(III), and 3% for domestic cats and lynx (V, VI). The target sample sizes therefore 
comprised at least 150, 75, 50 and 50 necropsied animals, respectively. For the squirrels 
(IV), no previous estimates of mortality rate were available to serve as the basis for a 
calculation, so the sample was a convenience sample.  
4.3.2. Samples for serology 
4.3.2.1. Moose and deer (I)  
The 1215 moose samples originated from all 15 game management districts (61-114 
samples from each). The 135 white-tailed deer samples and 17 roe deer samples originated 
from the south-western game management districts where their populations are the largest. 
 
Participating hunters voluntarily collected the samples from wild cervids during the 2008-
2009 hunting season. The sampling packages (n = 2917) were sent to the 15 game 
management districts for subsequent distribution to the hunters. Each package contained 
two plastic blood sample tubes (VACUETTE® Serum Clot Activator, Greiner Bio-One 
GmbH, Kremsmünster, Austria) to be filled with blood. The participation rate was 47%; 
during the study period, 1367 sample packages arrived at the laboratory by mail within 
four days of each kill. Upon arrival, the sera were separated by centrifugation, divided into 
aliquots, and stored at -20°C until analyzed.  
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4.3.2.2. Sheep (I) 
The 1940 individual sheep samples originated from 97 separate flocks: 20 samples per 
flock, 10-22 flocks from each of the six provinces.  
 
The Finnish Food Safety Authority Evira provided these aliquots of sheep sera, which 
local municipal veterinarians drew from sheep over one year of age for a disease 
surveillance program in 2008. The serum aliquots were stored frozen at -20°C until 
analyzed. 
4.3.2.3. Farmed wild boars (II) 
The 197 farmed wild boar sera selected for this study were collected in 2007-2008. They 
originated from 25 separate farms, each with 6-150 animals, and each providing 1-43 
samples.  
 
This survey was part of a nationwide epidemiological study with voluntary sampling by 
wild boar farmers in 2005-2008. The animals were stunned and bled on the farms, and the 
farmers collected the blood samples. The samples were then sent to the laboratory within 
three days, and the sera were separated and stored frozen at -20°C until analyzed.  
4.3.2.4. Hares (III) 
From May 2006 to April 2009, veterinary pathologists at the Finnish Food Safety 
Authority Evira collected sera from 116 European brown hares and 99 mountain hares, 
which private citizens had voluntarily submitted for post-mortem examination. The sera 
were stored frozen at -20°C.  
4.3.2.5. Domestic cats (V) 
The DNA bank plasma samples were from 445 purebred cats from across Finland, 
whereas the plasmas or sera from 45 shelter cats came from a shelter located in the capital 
city of Helsinki in southern Finland. The samples were collected between September 2008 
and August 2009, and the sera or plasmas were separated and stored at -20°C until 
analyzed. 
4.3.2.6. Lynx (VI) 
The 337 lynx samples originated from across the mainland of Finland based on granted 
hunting permits: more lynx were hunted in areas with a high lynx population.  
 
 
 
 
44 
 
The lynx samples for serology were serosanguineus fluid samples collected from thawed 
hearts. During the hunting season from December 2010 to February 2011, hunters sent 
lynx carcasses to a field station of the Finnish Game and Fisheries Research Institute, 
where the hearts were removed, sealed in individual plastic bags, and shipped frozen to the 
laboratory. 
4.3.3. Fecal samples 
4.3.3.1. Cats (V) 
Fresh fecal samples from litter boxes were collected in 2009 from 131 shelter cats. 
 
Individual fecal samples were collected from 76 cats, and pooled samples were collected 
from 55 cats kept in groups. The majority (n = 117) of the cats sampled were impounded 
at two cat shelters located in the capital city of Helsinki in southern Finland, 12 in Vaasa, 
and two in Rovaniemi.  
 
The samples were stored at +4°C for a maximum of seven days and analyzed. 
4.3.3.2. Lynx (VI) 
Individual fecal samples were collected directly from the rectum of 332 lynx at the field 
station of the Finnish Game and Fisheries Research Institute in 2010-2011. For logistical 
reasons, these samples had to be shipped and stored frozen until analyzed. 
4.3.4. Animals submitted for postmortem examination 
4.3.4.1. Hares (III) 
Private citizens voluntarily submitted the hares to the Finnish Food Safety Authority Evira 
for postmortem examination. The hares included in the study (173 European brown hares 
and 148 mountain hares) were examined by the veterinary pathologists over a three-year 
period from May 2006 to April 2009; the length of the study period was based on the 
sample size calculations. 
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4.3.4.2. Squirrels (IV) 
Between May 2006 and April 2009, private citizens submitted the squirrels included in the 
study to the Finnish Food Safety Authority Evira for postmortem examination. Due to the 
lack of previous estimates, this time period was designated to be the same as for the hares 
with no specific sample size calculation. The convenience sample comprised 19 squirrels. 
4.3.4.3. Domestic cats (V) 
The database search was carried out among all domestic cats examined postmortem at the 
Veterinary Pathology Department, Faculty of Veterinary Medicine, University of Helsinki, 
between January 2008 and June 2011 (n = 193).  
4.3.4.4. Lynx (VI) 
The database search of the wildlife pathology laboratory of the Finnish Food Safety 
Authority Evira included all lynx submitted for postmortem examination between January 
2000 and May 2010 (n = 167). 
4.3.5. Fresh and frozen tissue samples 
4.3.5.1. Domestic cats (V) 
Since 2008, the veterinary pathologists at the Faculty of Veterinary Medicine, University 
of Helsinki, informed of all feline cases in which toxoplasmosis was suspected based on 
clinical history or suggestive gross findings observed during necropsy. Fresh samples of 
different tissues (brain, heart, liver, lung, lymph node) from all such cats were collected 
with sterile instruments for T. gondii isolation. In addition, selected tissue samples of the 
same cats were stored frozen.  
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4.4. Controls and reference samples 
Control samples were included in all analyses. In the methods with several steps, they 
were introduced at different steps in order to control for them separately. For the 
molecular methods in particular, this entailed several controls in the final analyses, but this 
practice ensured that the methods worked without problems and ruled out contamination. 
 
For serology, all plates included the negative and positive controls provided in the kit at 
two dilutions: 1:40 and 1:4000. The antigen control (all reagents but the serum) was 
carried out in two wells on each plate.  
 
For immunohistochemical staining, sections with no primary antibody and tissue sections 
known to be positive or negative for T. gondii served as controls. The negative control 
tissue sections came from the same species: formalin-fixed, paraffin-embedded (FFPE) 
liver tissue from a European brown hare that had died of listeriosis (III), FFPE tissues 
from a Eurasian red squirrel that had died of head trauma (IV), and liver tissue from a cat 
euthanized due to a Pasteurella multocida infection (V). The positive control tissue was 
liver tissue from a cat that had died of generalized toxoplasmosis, confirmed with all 
methods available in the laboratory. 
 
Alongside DNA extraction from the samples, DNA was extracted from at least one 
negative control (nuclease-free water) and at least one positive control (T. gondii 
tachyzoites cultivated in cell cultures). Tissues from the same host species as the samples 
were included, if available, from individuals confirmed to be free of T. gondii or 
confirmed to be infected with T. gondii. The DNA extracts from the controls served as 
controls in all subsequent molecular methods.  
 
For the molecular methods, more references and controls were included as DNA, whether 
frozen DNA from previous rounds of DNA extraction in our lab or obtained from other 
laboratories. DNA from the Neospora caninum strain NC1 (provided by Dr. Katarzyna 
Gozdzik of the Witold Stefański Institute of Parasitology in Warsaw, Poland) and 
nuclease-free water always served as negative controls. In addition, DNA extracted from 
uninfected cell cultures and from tissue samples of known T. gondii-negative animals of 
the same species were included as controls. DNA samples from selected T. gondii parasite 
strains served as positive controls and references. These included the strains RH (genotype 
I; provided by Eva-Britt Jakubek of the National Veterinary Institute in Uppsala, Sweden), 
GIL (genotype I), PSP-2007-TON (genotype II), PRU (genotype II), TOU-2004-FEU 
(genotype III), and NED (genotype III; provided by Dr. Daniel Ajzenberg and Professor 
Marie-Laure Dardé of the Toxoplasma Biological Resource Centre in Limoges, France), 
as well as FIN1 (genotype II) and FIN2 (genotype II; the local strains isolated in these 
studies (V; Table 7)). Controls were also routinely added after the PCR step as products 
from earlier PCR runs to control for the quality and repeatability of the last steps of the 
method. 
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In case a new strain yielded a genotyping result identical to one of the references used, the 
analysis was repeated from the original material with the reference strain removed from 
the controls in order to rule out cross contamination. In addition, analysis was carried out 
separately at each marker (not as a multiplex PCR) to confirm the results when needed; 
and more fingerprinting markers could have been used, if necessary. 
 
Strains RH, PSP-2007-TON, FIN1, and FIN2 were cultivated in cell cultures and 
cryopreserved to provide reference material. The RH strain was obtained from cell 
cultures of National Veterinary Institute, Sweden. PSP-2007-TON was obtained from the 
Toxoplasma Biological Resource Centre, Limoges, France, as a suspension of the CNS of 
an infected laboratory mouse. FIN1 and FIN2 are local strains isolated from domestic cats 
with fatal generalized toxoplasmosis (V). The reference cultures were regularly checked 
with diagnostic PCR and MS genotyping to confirm that no cross-contamination occurred 
between the strains or in the uninfected cell lines.  
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4.5. Serology 
4.5.1. Direct agglutination test 
A commercial direct agglutination test (DAT; Toxo-screen DA, bioMérieux, Marcy-
L’Étoile, France), a screening test for specific anti- Toxoplasma gondii IgG antibodies, 
was chosen as the serology method for these studies. The principle of the method is the 
agglutination of formalin-treated Toxoplasma parasites if the sample contains specific IgG 
antibodies. Possible IgM is denatured by 2-mercaptoethanol (2-ME) (Johnson et al., 
1989).  
 
The method was performed according to the manufacturer’s instructions. The results were 
read after 18 hours, and a light table providing even illumination from below or a spot 
light source served to assist with reading and to eliminate problems caused by background 
color in the hemolyzed samples.  
 
We used a four-point scale to record the results: 
 
3 – positive – an unshrunken mat covering the majority of the bottom of the well 
2 – positive – a large mat covering at least half of the bottom of the well 
1 – negative – a ring or mat covering less than half of the bottom of the well 
0 – negative – a button. 
 
These results were further interpreted as a dichotomous outcome: seropositive = 1 or 
seronegative = 0. That is, instead of including borderline results (result ‘1’ on our four-
point scale), as the manufacturer suggests, only clear positives were considered positive; 
all the rest, including those showing a borderline reaction, were interpreted as negative.  
 
The cut-off for seropositivity was 1:40 for all samples. Most samples were diluted to only 
1:40; any samples that tested positive at this dilution were defined as seropositive (I, II, 
III, V, VI). Only the samples of purebred cats (V) were diluted to 1:40 and 1:4000; 
samples that tested positive at either or both of these dilutions were defined as 
seropositive.  
 
A subsample of 80 feline samples (V) and 9 sera from hares that had died of generalized 
toxoplasmosis (III) that were available in sufficient quantities were further diluted to 1:60, 
1:180, 1:540, 1:1620, 1:6000, 1:18 000, 1:54 000, and 1:162 000 to determine the titers. 
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4.5.2. Blind experiment to evaluate the effect of hemolysis 
In 2008, we performed a blind experiment to test whether hemolysis affected the results of 
the DAT. The details of this experiment have not been published previously.  
 
For this test, we used blood samples from one T. gondii seropositive and one seronegative 
person. One sample from both persons each was processed routinely, while hemolysis was 
introduced to the others in selected ways: one sample was frozen, one was shaken 
vigorously, one was mixed with a small amount of tap water, and one was permitted to rot 
(left uncapped at room temperature). The sera were separated by centrifugation and 
divided into two aliquots. One of the aliquots served directly as a sample for DAT, and the 
other to test a commercially available method for clearing hemolyzed samples 
(HemogloBind, Biotech Support Group, Monmouth JCT, NJ, USA) prior to DAT. The 
removal of hemoglobin was carried out according to the manufacturer’s instructions. 
 
The sera were coded to conceal their identity during the DAT and when reading the 
results. The hemolysis was naturally visible.  
 
The coded sera were stored frozen until analyzed, as were the research samples, and DAT 
was performed according to the manufacturer’s instructions at two dilutions: 1:40 and 
1:4000. The controls provided in the kit were included on the plate. The results were 
recorded using the four-point scale above. 
4.6. Coprological investigations 
Fecal samples from possible definitive hosts of T. gondii were screened for the presence of 
T. gondii-like oocysts using flotation techniques. The technique selected as the main 
method is based on the use of a special FLOTAC apparatus (University of Naples 
Federico II, Naples, Italy) for flotation with saturated MgSO4 (magnesium sulphate; VWR 
International, Leuven, Belgium) solution, centrifugation, and transferring the top portion 
of the suspension aside for light microscopy. This was carried out as described in the 
instructions of the manufacturer of the FLOTAC apparatus. The screening was performed 
at 100X and 200X magnifications, and further examination at 400X.  
 
Of each sample from domestic cats, two parallel five-gram samples were examined, 
whereas only one five-gram sample was examined from each lynx. When T. gondii-like 
oocysts were detected, the oocyst-rich top portion was collected and then frozen and 
thawed three times prior to DNA extraction (QIAamp DNA Stool Mini Kit, Qiagen 
GmBH, Hilden, Germany). DNA was extracted according to the manufacturer’s 
instructions, and stored frozen until analysed with diagnostic PCR and direct genotyping.  
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4.7. Questionnaires 
The questionnaires for the hunters of moose, deer, and lynx inquired about the animal’s 
species (I, in areas where both deer and moose were sampled), age-group (calf or adult) 
(I), sex (I, VI), the geographical location of the kill (I, VI), additional information about 
the hunt (VI), and the hunter’s contact information. The questionnaires for wild cervids 
were color-coded: one color for areas where only moose were sampled and another for 
areas where all three cervid species were sampled. The personnel of the Taivalkoski field 
station of the Game and Fisheries Research Institute provided detailed measurements of 
the lynx. 
 
The questionnaire for the wild boar farmers (II) inquired about background information on 
the farms and animals, including the age and sex of the animals, the type and size of the 
herd, and the size and location of the farm. 
 
The questionnaire for the cat owners (V) included the cat’s signalment (e.g. date of birth, 
date of death, sex, breed, blood group), lifestyle (diet, outdoor access, international 
activities), and disease history (also of the cat’s close relatives).  
4.8. Clinical data 
All clinical data available for the domestic cats that died of toxoplasmosis (V) were re-
evaluated and summarized. The data included observed clinical signs and their duration, 
the laboratory results of clinical chemistry analyses and hematology, and the results of 
examinations of fecal samples. 
 
Clinical data from the other hosts examined were unavailable. The hunted animals (I, VI) 
as well as the animals raised for human consumption (I, II) presumably appeared to be 
healthy. The animals submitted for postmortem examination (III, IV, V, VI) were found 
dead or euthanized.  
 
The disease history of the cats (V) whose owners completed the questionnaires provided 
only limited information with apparent relevance to T. gondii infections. The diseases or 
disease groups mentioned were included in the premilinary analyses of associations, and 
in particular, any associations of the infection with reproduction or behavioral problems 
warranted further study. 
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4.9. Pathology and histopathology 
The postmortem diagnoses were made at the Veterinary Pathology Department, University 
of Helsinki (V) and the Finnish Food Safety Authority Evira (III, IV, VI) and were re-
evaluated in these studies (III, IV, V, VI). The original necropsy reports and histological 
tissue sections of the domestic cats that died of generalized toxoplasmosis (V) were re-
evaluated in detail, together with one specialist in veterinary pathology (Outi Simola, 
DVM, DipECVP), to obtain comparable data from the cases. 
 
The diagnoses were based on necropsy findings and the routine histologic examination of 
tissue samples. In addition, special stainings, bacterial cultures and other investigatons 
were carried out as needed. 
 
The necropsies were performed according to standard protocols, and morphological 
diagnoses were recorded. The tissue samples routinely taken from the main organs, as well 
as the additional samples taken as needed, were fixed in 10% neutral buffered formalin 
and processed into paraffin-embedded tissue blocks. The samples were sectioned and 
stained with hematoxylin and eosin (HE) for microscopic evaluation. The diagnoses were 
then entered into the databases of the Veterinary Pathology, University of Helsinki (V) 
and the Finnish Food Safety Authority Evira (III, IV, VI).  
4.10. Immunohistochemistry 
Immunohistochemical staining (IHC) for T. gondii was perfomed to confirm the diagnoses 
of toxoplasmosis (III, IV, V) and to evaluate the burden and spread of the parasites in 
different tissues (IV, V). The 4-µm sections of liver (III, IV, V) and other available tissues 
(IV, V) were routinely processed (Lab Vision PT Module, Lab Vision Corporation, 
Fremont, CA, USA) for automated IHC staining (Lab Vision Autostainer 480, Lab Vision 
Corporation).  
 
The primary antibody was selected from three commercial antibodies, the performances of 
which were tested in both manual and automated immunohistochemical staining. Citrate 
buffer (pH 6.0) was the solution used for heat-induced antigen retrieval, breaking the 
protein cross-links that might mask the antigenic sites.  
 
The preferred antibody selected for further optimization of the IHC method was 
Toxoplasma gondii epitope-specific rabbit antibody (Thermo Fisher Scientific, Runcorn, 
UK). The protocol optimized for automatic staining entailed a 1:500 dilution of the 
primary antibody and reagents from a labeled streptavidin-biotin immunoenzymatic 
antigen detection system (UltraVision Detection System, Anti-Polyvalent, HRP/DAB kit; 
Lab Vision Corporation).  
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4.11. Isolation, maintenance and cryopreservation of T. gondii in cell 
cultures 
In 2007, cell culture techniques for maintaining T. gondii strains were adapted to the 
laboratory (biosafety level 2) at the Department of Veterinary Biosciences, University of 
Helsinki, from the National Veterinary Institute i Sweden. The adapted protocols included 
the cultivation and quantification as well as the freezing and thawing of cells and T. gondii 
parasites. The main changes to the original protocols included simplifying the reagent list 
with commercial products, donning more personal protective equipment, and employing a 
specific freezing container to achieve more constant and optimal cooling rates.  
 
African green monkey (Chlorocebus sp.) kidney epithelial cells (Vero cells, European 
Collection of Cell Cultures, Salisbury, UK) were grown in T25 flasks (Easy Flask 25 V/C, 
NUNC A/S, Roskilde, Denmark) in Dulbecco’s modified Eagle medium 
(DMEM+GlutaMAX-I, Life Technologies Ltd., Paisley, UK) and 10% fetal bovine serum 
(Thermo Fischer Scientific, Cramlington, Northumberland, UK). Sub-culturing at optimal 
confluency was carried out with a recombinant enzyme, an animal origin-free alternative 
for trypsin, for detaching the cells (TrypLE Express, Life Technologies). 
 
The incubator (Serie CB Incubator, Binder GmbH, Tuttlingen, Germany) maintained the 
temperature at 37°C and the CO2 concentration at 5%. Its water bath was cleaned weekly 
with 70% ethanol and refilled with one liter of ultrapure water (MilliQ, EMD Millipore 
Corporation, Billerica, MA, USA). 
 
The cryopreservation of cells and parasites was further optimized by including a freezing 
container that promises an optimal rate of cooling for cell preservation, close to -1°C/min 
(Mr. Frosty Cryo 1°C Freezing Container, Nalgene, Thermo Scientific). The freezing 
medium was a fully supplemented commercial medium (Recovery cell culture freezing 
medium, Life Technologies), and an electric freezer was used for ultra-low temperature 
storage (Sanyo Ultra Low MDF-C2156VAN, Sanyo Electric Co. Ltd., Osaka, Japan). 
 
The isolation of T. gondii parasite strains from the tissues of animals with a suspected 
toxoplasmosis diagnosis was attempted directly into cell cultures. Small samples of the 
tissues (CNS, heart, liver, lung, lymph node) were first aseptically cut into pieces with 
sterile instruments, then further homogenized with a syringe by injecting them through a 
hypodermic cannula (18G), and finally poured onto fresh cell cultures. 
 
Penicillin and streptomycin (PenStrepGlutamine, Life Technologies) were added to the 
flasks for the first two passages when attempting a new isolate. All other cultures were 
antibiotics free, and the protocols were strictly aseptic. 
 
All the cultures were regularly examined for cell and parasite growth and monitored for 
other possible changes with an inverted contrasting microscope (Leica DM IL, Leica 
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Microsystems GmbH, Wetzlar, Germany). Any flasks with color changes reflecting 
unexpected changes in pH or showing signs of microbial contamination were discarded.  
 
A digital microscope camera (Leica DFC425 with Leica Application Suite (LAS) 
software, Leica Microsystems) served to document growth in the flasks. In addition, thin 
pieces of glass were placed on the bottom of selected flasks and removed for cytological 
staining (modified Giemsa) after fixation with methanol or 10% neutral buffered formalin. 
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4.12. DNA extraction 
The tissues of the animals that died of generalized toxoplasmosis (III, IV, V) were rich in 
T. gondii parasites in IHC, and DNA was extracted directly from them for further 
investigations with molecular methods. Both FFPE and frozen tissues were used when 
available. In addition, DNA was routinely extracted from frozen samples of cell cultures 
to confirm successful isolations (V) and the integrity of the strains maintained in the cell 
cultures. DNA was also extracted from fecal samples that tested positive for T. gondii-like 
oocysts (V).  
 
The main DNA extraction kit (the DNA IQ™ System and Tissue and Hair Extraction Kit; 
Promega, Madison, WI, USA) was selected based on previous experience, as well as for 
its applicability to the FFPE samples. This method uses paramagnetic resin to bind the 
DNA and thus requires less centrifugation and washing. The extractions were performed 
according to the manufacturer’s instructions. The FFPE samples were incubated in the 
Incubation Buffer/Proteinase K solution overnight; the other samples, for two hours. The 
amount of resin per sample was increased to 10 µl, and the final elution volume was 
adjusted to 30 µl in order to strike a good compromise between DNA yield and final 
volume. 
 
Three freeze-thaw cycles and a special DNA extraction method for fecal samples 
(QIAamp DNA Stool Mini Kit, Qiagen) were used to extract DNA from flotation-enriched 
fecal samples with T. gondii-like oocysts (V).  
 
When necessary, the DNA samples were stored frozen at -20°C until analyzed. Archives 
of these DNA remain frozen in storage. 
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4.13. Detection of T. gondii DNA with PCR 
The diagnostic PCR protocol established targets the 529-bp fragment that is repeated 200- 
to 300-fold in the T. gondii genome (Homan et al., 2000).  
 
For this PCR, the total volume of 50 µl comprised a commercial master mix (2x PCR 
Mastermix, Promega) at a final concentration of 1x, 0.5 µM of primers (Oligomer, 
Helsinki, Finland; Table 2), 7 µl of DNA, and nuclease-free water (Nuclease-free water, 
Promega). The PCR conditions in the PTC-200 Peltier Thermal cycler (MJ Research Inc., 
Waltham, MA, USA) were 94°C for seven minutes followed by 35 cycles of 94°C, 55°C, 
and 72°C for one minute each, and a final ten-minute extension at 72°C. The results were 
visualized under ultraviolet light after electrophoresis on 2% Tris-Acetate-EDTA (TAE) 
agarose gel (NuSieve 3:1 Agarose, Cambrex BioScience Rockland Inc., Rockland, ME, 
USA) with ethidium bromide. 
 
Table 2 The PCR primers used for the diagnostic PCR for Toxoplasma gondii.  
   
 Primer sequence Reference 
   
   
TOX4 5’ CGCTGCAGGGAGGAAGACGAAAGTTG 3’ (Homan et al., 2000) 
TOX5 5’ CGCTGCAGACACAGTGCATCTGGATT 3’ (Homan et al., 2000) 
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4.14. Direct genetic characterization of T. gondii parasites 
A genotyping method based on microsatellite markers was adapted from the laboratory of 
the University of Limoges, France. The major changes made to the original protocol 
(Ajzenberg et al., 2005) included a different fluorescent label for the marker W35 in order 
to improve the resolution between it and M48 (same change in the updated method 
described in Ajzenberg et al., 2010), as well as the number of cycles, and the temperature 
and time of the annealing step of the PCR.  
 
The method is based on length polymorphism analysis of microsatellite markers after 
multiplex PCR. Six of the markers we used (B18, TUB2, TgM-A, W35, B17, and M33) 
are well described for genotyping (Blackston et al., 2001; Ajzenberg et al., 2005), and 
additional markers have been described for fingerprinting (Blackston et al., 2001; 
Ajzenberg et al., 2010), that is, for distinguishing closely related isolates. In our method, a 
seventh marker, fingerprinting marker M48, was included for further characterization. The 
results obtained with the genotyping markers are identical to those of the reference strain 
of the same genotype, while the fingerprinting marker M48 can show variation beyond the 
genotype level. In case of a mixed infection with two strains belonging to the same 
genotype, this marker could show the mixed infection (two peaks). Another reason for 
keeping this seventh marker in the analysis was to rule out contamination. If a result from 
a sample was fully identical to a reference strain, the analysis was repeated from the very 
beginning, from the original material, without that particular reference strain in the same 
run. If necessary, further analysis with more fingerprinting markers was available.   
 
The total volume of 25 µl for the multiplex PCR comprised a commercial master mix (2x 
QIAGEN Multiplex PCR Master Mix; Qiagen) at a final concentration of 1x, 0.04 µM of 
each primer (Applied Biosystems, Warrington, UK; Table 3), 5 µl of nuclease-free water 
(Nuclease-free water, Promega), and 4 µl of DNA. The forward primers were 5’-end 
labeled with 6-carboxyfluorescein (B18, TUB2, and M48), hexachlorofluorescein (TgM-
A, W35, and B17), or 2,7’,8’-benzo-5’-fluoro-2’,4,7-trichloro-5-carboxyfluorescein 
(M33). The PCR conditions in the PTC-200 Peltier Thermal cycler (MJ Research) were 
95°C for 15 minutes followed by 40 cycles of 94°C for 30 seconds, 61°C for four minutes, 
and 72°C for one minute, and a final thirty-minute extension at 60°C. The PCR products 
from DNA extracted from cell culture were diluted 1+30, and the DNA products of the T. 
gondii reference strains were diluted 1+20 in deionized formamide (Sigma-Aldrich Co, St. 
Louis, MO, USA). One microliter of each diluted or undiluted product was then mixed 
with 23.5 µl of deionized formamide and 0.5 µl of size standard (GeneScan 500 ROX Size 
Standard, Applied Biosystems) before being taken to the Institute of Biotechnology for 
automated capillary electrophoresis (3130xl Genetic Analyzer, Applied Biosystems). The 
products were separated based on size, and identified based on the fluorescent labels. The 
data were analysed, and the sizes of the alleles estimated by comparing with the sizing 
curve using a free software (PeakScanner Software version 1.0, Applied Biosystems; 
Figure 5). A variation of the method, in which each primer pair was used separately, 
enabled further resolution and confirmation of the identity of the markers, when necessary. 
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Table 3 The PCR primers of the MS genotyping method.  
   
 Primer sequence Reference 
   
   
Genotyping markers*  
   
B18 [TG/AC]n  
(Ajzenberg et al., 2005; 
Ajzenberg et al., 2010) 
FB18 5’ 6-FAM-TGGTCTTCACCCTTTCATCC 3’ 
RB18 5’ AGGGATAAGTTTCTTCACAACGA 3’ 
   
TgM-A [TG/AC]n  
(Ajzenberg et al., 2005; 
Ajzenberg et al., 2010) 
FTgM-A 5’ HEX-GGCGTCGACATGAGTTTCTC 3’ 
RTgM-A 5’ TGGGCATGTAAATGTAGAGATG 3’ 
   
W35 [TC/AG]n, [TG/AC]n 
(Ajzenberg et al., 2005; 
Ajzenberg et al., 2010) 
FW35 5’ HEX-GGTTCACTGGATCTTCTCCAA 3’ 
RW35 5’ AATGAACGTCGCTTGTTTCC 3’ 
   
B17 [TC/AG]n  
(Ajzenberg et al., 2005; 
Ajzenberg et al., 2010) 
FB17 5’ HEX-AACAGACACCCGATGCCTAC 3’ 
RB17 5’ GGCAACAGGAGGTAGAGGAG 3’ 
   
TUB2 [TG/AC]n  
(Ajzenberg et al., 2005; 
Ajzenberg et al., 2010) 
FTUB2 5’ 6-FAM-GTCCGGGTGTTCCTACAAAA 3’ 
RTUB2 5’ TTGGCCAAAGACGAAGTTGT 3’ 
   
M33 [TC/AG]n  
(Blackston et al., 2001; 
Ajzenberg et al., 2010) 
FM33 5’ NED-TACGCTTCGCATTGTACCAG 3’ 
RM33 5’ TCTTTTCTCCCCTTCGCTCT 3’ 
   
   
Fingerprinting marker  
   
M48 [TA/AT]n  
(Blackston et al., 2001; 
Ajzenberg et al., 2010) 
FM48 5’ 6-FAM-AACATGTCGCGTAAGATTCG 3’ 
RM48 5’ CTCTTCACTGAGCGCCTTTC 3’ 
   
* The repeat motif(s) in square brackets; F = forward primer, R = reverse primer, 6-FAM = 6-
carboxyfluorescein, HEX = hexachlorofluorescein, NED = 2,7′,8′-benzo-5′-fluoro-2′,4,7-trichloro-
5-carboxyfluorescein. 
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4.15. Statistical analyses 
Two-by-two tables and test statistics (mainly chi-square and mid-P exact) of open source 
software for epidemiological statistics served to evaluate simple associations (Dohoo et 
al., 2003; Dean et al., 2013) and to make preliminary comparisons (I, II, III, IV, V, VI). 
Confidence intervals were computed using mid-P exact (Lydersen et al., 2009; Dean et al., 
2013). P values < 0.05 were considered statistically significant.  
 
Logistic regression analyses with Stata 9.2 (I) and 11.0 (II, V, VI) software (StataCorp, 
College Station, TX, USA) were used to evaluate the combined effect of selected 
variables. The variables were selected not only based on their presumed biological 
relevance; we also tested the fit of other available variables to the models. The 
multivariable models were built stepwise using forward selection and backward 
elimination, as well as testing for interaction and confounding. For the wild boar data, 
further analysis included building a random effects logistic model to account for herd 
effects (II). 
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5. Results 
5.1. Anti-Toxoplasma gondii IgG antibodies in all host species 
investigated 
Anti-Toxoplasma gondii IgG antibodies were detected in some animals of all the host 
species investigated (I, II, III, V, VI; Table 4) at the sample dilution of 1:40. The highest 
seroprevalence estimate was for lynx (VI), and the lowest ones were for the hares (III).  
 
Table 4 Toxoplasma gondii seroprevalences in Finland (I, II, III, V, VI). 
     
 N n positive Prevalence (%) 95% CI 
     
     
Domestic sheep 1940 477 24.6 22.7-26.5 
     
Moose 1215 116 9.6 8.0-11.3 
     
White-tailed deer 135 36 26.7 19.7-34.6 
     
Roe deer 17 3 17.6 4.7-40.9 
     
Farmed wild boar 197 65 33.0 26.7-39.8 
     
European brown hare 116 9 7.8 3.9-13.8 
     
Mountain hare 99 7 7.1 3.1-13.5 
     
Domestic cat 490 237 48.4 44.0-52.8 
     
Eurasian lynx 337 290 86.1 82.0-89.5 
     
CI = 95% confidence interval 
 
 
Veterinary pathologists collected the sera from European brown hares and mountain hares 
during necropsies. The sample included sera from nine European brown hares and three 
mountain hares that died of acute generalized toxoplasmosis (confirmed in III). There 
were no seropositives among the 203 brown hares that died of other causes (0.0%; 95% CI 
 
 
 
 
60 
0.0-2.8), as opposed to four seropositives among the 96 mountain hares that died of other 
causes (4.2%; 95% CI 1.3-9.7; P < 0.05).  
 
Seroprevalence among female cats with reported abortions, stillbirths, or other 
reproduction problems (66.7%) was higher than the overall seroprevalence (P < 0.05). The 
seroprevalence in cats with reported behavioral problems (53.2%) was similar to the 
overall seroprevalence.  
5.1.2. Hemolysis has no effect on the results of the serology method 
In our blind experiment, hemolysis had no effect on the DAT results (Table 5). The only 
false-negative result was from the positive sample that was experimentally hemolyzed by 
adding a small amount of tap water, at a dilution of 1:4000. By contrast, applying the 
method to remove hemoglobin affected the results (Table 5). Three aliquots of the positive 
sample yielded a false negative result at a dilution of 1:40, and all did so at a dilution of 
1:4000. 
 
Table 5 The results of the blind experiment show the effect of experimental hemolysis on 
the results of the serology method at the two dilutions. The results appear on a 
four-point scale: 0 and 1 are negative; 2 and 3 are positive.  
     
 Known negative sample Known positive sample 
Dilution 1:40 1:4000 1:40 1:4000 
     
     
Non-hemolyzed 0 0 3 2 
Non-hemolyzed, hemoglobin removed 0 0 2 0* 
     
Frozen 0 0 3 2 
Frozen, hemoglobin removed 0 0 3 0* 
     
Shaken 0 0 3 2 
Shaken, hemoglobin removed 0 0 0* 0* 
     
Mixed with water 0 0 3 1* 
Mixed with water, hemoglobin removed 0 0 1* 0* 
     
Rotten 0 0 3 3 
Rotten, hemoglobin removed 0 0 1* 0* 
     
* False negative result 
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5.2. Risk factors for Toxoplasma gondii infections 
5.2.1. Age 
Adult age was a significant risk factor in moose (I), white-tailed deer (I), farmed wild 
boars (II), domestic cats (V), and lynx (VI). In moose, white-tailed deer, and cats, the odds 
of testing seropositive were about three times higher in adults than in those under one year 
old. In the wild boar, animals older than 24 months had two times higher odds for 
seropositivity than did the younger age group. Lynx presumably over one year old had 
14.3 (95% CI 5.0-41.0) times higher odds for testing seropositive than did lynx of a 
presumed age of 7-10 months. The odds of testing seropositive increased by 20% for 
every year increase in the cat’s age (V). Although the exact ages of the lynx were 
unknown, their odds for testing seropositive increased by 1.5 for each kilogram gained in 
weight (VI).  
 
Age was a confounder in the simple logistic regression models for moose and farmed wild 
boar, whereas no interaction was evident between age and sex. Weight was confirmed as a 
confounder in lynx: it was related to seropositivity and sex.  
5.2.2. Geographic location  
Especially in moose, the latitude gradient observed in seroprevalence was striking (I). 
Seroprevalence in the south was over 15 times higher than in the north, with no explaining 
age distribution difference in the samples from these locations. A similar geographical 
north-south gradient in seroprevalence was also evident in domestic sheep (I), farmed wild 
boars (II), and lynx (VI).  
5.2.3. Winter 
Most of the fatal cases (79%) in brown hares were diagnosed during the coldest winter 
months. The proportional mortality rate from toxoplasmosis was eight times higher (P < 
0.001) during the coldest winter months than in the other months.  
5.2.4. Human actions 
Detailed information about possible sources of T. gondii infection or preventive measures 
implemented on the sheep and wild boar farms was unavailable (I, II). Outdoor access was 
a significant risk factor for T. gondii infections of domestic cats in univariable analysis 
with an odds ratio of 1.6 (V). More than half of the cats (58.2%) had outdoor access. 
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Providing the cat with raw meat in its diet was a common practice (78.4%) and a 
significant risk factor with an odds ratio of 2.0 (V).  
5.3. Contribution of the definitive hosts: ongoing shedding 
Toxoplasma gondii-like oocysts were detected in the fecal samples of two domestic cats, 
one of which was confirmed with PCR to be shedding T. gondii at the time of sampling. 
None of the fecal samples from lynx had detectable T. gondii-like oocysts. The PCR-
confirmed T. gondii oocyst shedding prevalence was thus 0.8% (95% CI 0.04-3.7) in 
domestic cats, which did not differ significantly from the 0.0% (95% CI 0.0-0.9) found in 
lynx.  
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5.4. Naturally-acquired fatal infections with endemic genotype II 
5.4.1. Proportional mortality rates from toxoplasmosis 
In the material examined postmortem, toxoplasmosis was detected and confirmed to be 
among the causes of death in brown hares (III), mountain hares (III), squirrels (IV) and 
domestic cats (V), but not among the lynx (VI; Table 6).  
 
Table 6 Proportional mortality rates from toxoplasmosis in Finland (III, IV, V, VI). 
     
 N 
n died of 
toxoplasmosis 
Proportional mortality 
rate (%) 
95% CI 
     
     
Brown hare 173 14 8.1 4.7-12.9 
     
Mountain hare 148 4 2.7 0.9-6.4 
     
Squirrel 19 3 15.8 4.2-37.2 
     
Domestic cat 193 6 3.1 1.3-6.4 
     
Lynx* 167 0 0.0 0.0-1.8 
     
CI = 95% confidence interval 
* Proportional mortality rate expresses mortality due to a specific cause in dead animal material 
(Dohoo et al., 2003) and is inherently subject to variation in the material included. A major portion 
of these lynx was submitted to postmortem examination after traffic accidents and by police 
authorities, so this rate estimate is not comparable with those of other species.  
 
 
All the brown hares and mountain hares that died of toxoplasmosis and from which serum 
was available tested seropositive (III). All the brown hares that tested seropositive had 
died of toxoplasmosis (III). The proportional mortality rate was significantly higher in 
brown hares than in mountain hares (P < 0.04).  
 
The course of toxoplasmosis appeared to be acute in all cases. No concurrent, possibly 
predisposing other diseases or conditions were diagnosed. The hares that died of 
toxoplasmosis were heavier than those that died of other causes (III). The domestic cats all 
had a short history of illness and exhibited unspecific clinical signs for approximately one 
week (V). The observed clinical signs included apathy, inappetence, dehydration, fever, 
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respiratory signs, incoordination, and icterus. The most striking laboratory result was 
markedly elevated levels of the liver enzyme alanine aminotransferase.  
 
None of the cats had an antemortem diagnosis of toxoplasmosis (V), and in many of the 
cases, the diagnosis was evident no sooner than upon the histopathological evaluation of 
tissue samples. Gross postmortem findings in acute toxoplasmosis were unspecific and 
often scarce, with the exception of the enormous enlargement of the spleen 
(splenomegaly) which was confirmed in this study to be a typical finding in affected hares 
(III). 
 
The cases were all generalized, and the liver and lungs were the organs most consistently 
affected. The diagnoses were confirmed (III, IV, V), and the burden of T. gondii parasites 
in different tissues were evaluated (IV, V) with immunohistochemistry (Figure 2-4). Large 
to massive numbers of parasites were seen in nearly all tissue samples examined (III, IV, 
V). 
 
 
 
  
Figure 2 Immunohistochemical (IHC) staining of the liver tissue of a squirrel (case 3) that died 
of toxoplasmosis, showing numerous positively stained Toxoplasma gondii parasites. 
Scale bar 100 µm. 
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Figure 3 Immunohistochemical (IHC) staining of the spleen of a squirrel (case 1) that died of 
toxoplasmosis, showing numerous positively stained Toxoplasma gondii parasites. 
Scale bar 100 µm. 
 
Figure 4 Immunohistochemical (IHC) staining of the lung tissue of a squirrel (case 2) that died 
of toxoplasmosis, showing numerous positively stained Toxoplasma gondii parasites. 
Scale bar 100 µm. 
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5.4.2. Endemic genotype II infecting both domestic and wild hosts 
 
Toxoplasma gondii strains belonging to genotype II, which is endemic in Europe, was 
confirmed to be present and endemic in Finland also (III, IV, V). Genotype II was the only 
genotype detected, and no signs of mixed infections were evident (Figure 5, Table 7). 
Toxoplasma gondii strains belonging to this genotype caused all the fatal cases (III, IV, 
V). Genotyping proved successful from archived FFPE material as well (III, IV, Table 7). 
 
 
 
Figure 5 Direct genetic characterization of the local Toxoplasma gondii strain FIN1 from the 
fifth passage in the cell cultures. FIN1 was isolated from a domestic cat (case 5) that 
died of toxoplasmosis. Electropherogram from the analysis performed with 
PeakScanner software, showing the color-coded peaks together with the sizing 
standard (red) overlaid. The x-axis shows the sizes in basepairs; the y-axis, the peak 
heights in relative fluorescence units. 
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Despite the allele being shared by genotypes II and III, the estimated length of the PCR-
product at marker W35 fell consistently between 245 and 246 bp from the reference and 
local strains belonging to genotype II, and between 244 and 245 bp from the genotype III 
reference strains (Table 7).  
Two of the squirrels, those found dead together, yielded identical genotyping results at all 
markers, pointing to a common source of infection (Table 7). 
5.4.3. Local isolates 
Two T. gondii strains were isolated directly from the tissues of two local cats with 
generalized fatal toxoplasmosis (V). Rampant infection was evident by the third passage 
from the CNS and the myocardium samples from cat 5, and from the CNS and the lung 
tissue samples from cat 6. The first isolate was obtained in 2009 (FIN 1, from cat 5), and 
the second in 2011 (FIN 2, from cat 6). Their growth rate and pattern in the cell cultures 
resembled those of the genotype II reference strain PSP-2007-TON: multifocal coalescent 
disruption of the cell layer, ready for passage to a fresh cell flask approximately every 8-
10 days. 
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6. Discussion 
6.1. Strengths and limitations of the study  
6.1.1. Sample quality 
The blood samples from the sheep (I) and domestic cats (V) were taken, centrifuged, and 
stored according to routine protocols. The farmers collected the blood samples from 
farmed wild boars upon slaughter (II), and the hunters collected the blood samples from 
wild cervids after the kill (I). Many of the latter samples were exposed to temperatures 
below zero upon transportation to the laboratory via mail, and hemolysis was commonly 
observed in the sera. The sera from the blood samples collected from necropsied hares 
(III) and the serosanguineous fluid samples from the thawed lynx hearts (VI) were 
collected after a longer postmortem period, which likely affected their quality. Storing 
biological fluid samples at room temperature for weeks has been shown to decrease the 
proportion of them identified as seropositive with DAT (Jakubek et al., 2012); moreover, 
the degradation of antibodies and changes in the body fluid compartment after death 
affected the serological test results from dead animals stored at +10 °C within days 
(Tryland et al., 2006).  
 
Hemolysis due to freezing, prolonged time before sampling, or other reasons likely did not 
affect the results obtained. According to the manufacturer of the serology method, the 
DAT has been validated for use with good quality human sera, but not for hemolyzed, 
lipemic or icteric sera, or for biological fluids other than sera. However, hemolysis has 
been mentioned not to interfere with the test that has been used for a multitude of animal 
species (Dubey, 2010). Moreover, we found no effect when testing known anti-T. gondii 
antibody-positive and -negative samples hemolyzed in various ways, including freezing. 
The one false negative result observed in the positive sample hemolyzed by tap water was 
likely due to dilution. Interestingly, numerous false negative results were seen after 
attempting to clear the sera by removing hemoglobin (Table 5). A light table was used for 
reading the plates, which were also read from below against a light source; the background 
color present in some samples due to hemolysis did not impair the reading of the plates. 
This contrasts with the difficulties that others encountered in interpreting strongly 
hemolyzed samples at low dilution (De Craeye et al., 2011); worth noting is that the study 
made no mention of the use of a light table or other exogenous light source. 
 
The fecal samples from domestic cats (V) were collected fresh and analyzed within a 
week, a time period considered acceptable. For logistic reasons, the fecal samples from 
lynx (VI) had to be frozen, which did affect their quality, namely their consistency and the 
morphological appearance of the helminth eggs. Although we did not expect this to have 
influenced the detection of T. gondii-like oocysts, false negativity cannot be fully 
 
 
 
 
71 
excluded. Of note, other parasites were identifiable in the same lynx samples, including 
protozoans such as Eimeria sp. (from their prey) and Isospora sp. (Deksne et al., 2013).  
 
Overall, the lynx samples were the most problematic in terms of quality, due to the mid-
winter hunting season and the need to store and transport them to the field station before 
the laboratory. Consequently, some of the samples might actually have been exposed to 
freezing and thawing twice before analysis.  
6.1.2. Sample representativity 
The host species included in these studies are restricted and serve as examples of host 
species for T. gondii present in Finland. Some species not included in these studies might 
be even more relevant for the local epidemiology of this parasite or for its zoonotic risk to 
humans. Nevertheless, domestic cat is surely in the centre of T. gondii epidemiology 
(Dabritz and Conrad, 2010), and these studies cover a representative selection of both wild 
and domestic hosts. 
 
Hunting seasons were conveniently limited time periods to permit a cross-sectional study 
design, and organized cooperation with hunters made intensive, nationwide sampling 
possible (I, VI). Yet winter hunting seasons were challenging for the transport of samples, 
and very young animals were not sampled in these hunts. The inclusion of archived 
materials and databases, as well as cooperation with other ongoing research efforts (the 
feline DNA bank (V), disease surveillance programs and the projects of other groups at 
the University of Helsinki (II) and Evira (I, III, IV), as well as the game animal research of 
Finnish Game and Fisheries Research Institute (VI)) made it possible to achieve large 
sample sizes during limited periods of time (I, II, V, VI), and longer sampling periods to 
encompass seasonal variation (II, III, IV, V, VI).  
 
The hunter-harvested samples of moose (I) and lynx (VI) represent their respective 
populations well. More animals were hunted and sampled in areas with larger populations. 
A slight dominance of samples from males (56.6%, range 43.2.-71.3 in the game 
management districts) and adults (61.6%, range 51.1-75.0%) was evident in moose (I). 
The gender balance was surprisingly even in the lynx, given that female lynx accompanied 
by cubs under one year of age are protected from hunting (Hunting Act, 1993). Most 
sheep sera were from ewes, and the sampling frame covered only sheep over one year of 
age (I); most sheep are slaughtered for human consumption at a younger age than that. The 
majority of domestic cats (V) sampled for serology were purebred, pedigreed cats, 
whereas the majority of cats living in Finland are non-purebred. The sample thus 
represents mainly purebred pedigreed cats and was likely affected by the participatory 
activity of their owners. Four of the five breeds with the highest sample size in the study 
have been in the top ten most common cat breeds in Finland in recent years (Suomen 
Kissaliitto, 2011; Suomen Kissaliitto, 2013). However, the most common breed in the 
sample, Korat, is not among the most common breeds in the register. The seroprevalence 
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among Korat cats was the lowest of the five breeds, lowering the overall seroprevalence 
estimate. 
  
The sample sizes obtained exceeded the calculated sample sizes for all the host species 
and investigations, except for the deer for serology. The squirrels can be considered a 
convenience sample. Our hunter-harvested lynx sample size was exceptionally large 
compared with several other studies in this and other lynx species (Oksanen and Lindgren, 
1995; Ryser-Degiorgis et al., 2006; Garcia-Bocanegra et al., 2010; Dubey, 2010): 91% of 
all lynx legally hunted during the season and approximately 14% of the entire estimated 
population. Regardless, the actual number of animals examined remains more relevant 
than the proportion of the population sampled because a larger sample size (n) means 
narrower confidence intervals and diminishes the effect of any sampling bias. 
 
In the sampling from sheep for serology (I), the clustering of the sheep into flocks was 
taken into account, which dramatically increased the sample size needed. This is a relevant 
point to consider when sampling animals and evaluating prevalence estimates from 
animals kept in groups, as they are likely to have been similarly exposed. The presence 
and level, or lack, of oocyst contamination likely varies by farm. In addition, vertical 
transmission might be relevant in maintaining T. gondii infection in sheep (Duncanson et 
al., 2001; Williams et al., 2005; Hide et al., 2007; Hide et al., 2009). 
 
Most compromises had to be accepted with regard to the fecal samples. While the ages of 
most of the cats sampled were unknown, cats of different ages were included (V). Pooling 
the samples could not be avoided when sampling at the cat shelters, because many of the 
cats are kept in small groups, and we aimed to sample without causing the cats 
unnecessary distress (V). Individual samples would have been better than pooled samples 
to fully ensure that all the cats in the group were included. Due to the time of the hunting 
season, the fecal samples from lynx included no samples from very young cubs (VI). If 
shedding is expected to occur mainly after the primary infection, as in cats (Dabritz and 
Conrad, 2010), this could explain why no lynx were found to shed T. gondii. 
 
The animals submitted for postmortem examination (III, IV, V, VI) cannot be regarded as 
representing the populations well, and the results from different species are not fully 
comparable due to different motivation to submit animals of different species. The wild 
animals examined (III, IV, VI) included all animals of those species examined postmortem 
during the study periods because the Finnish Food Safery Authority Evira is the only 
laboratory that performs wildlife pathology in Finland, whereas domestic cats can be 
submitted for postmortem examination at places outside the University of Helsinki. Most 
domestic cats do not undergo postmortem examination after death or euthanasia, and the 
cost of the examination may have a selective effect. Hares and squirrels are typically 
submitted by individual citizens who want to know the cause of death of animals they 
have found dead, whereas the lynx material includes more animals that died in traffic 
accidents and were subsequently submitted for examination by the police. Overall, in the 
wildlife material submitted for pathology, animals found dead near human settlements and 
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roads are likely overrepresented because these animals are the most likely to be found 
dead by humans. Animals dying in more sparsely populated areas are more likely to be 
found by scavengers than by active citizens, and are thus likely underrepresented. To find 
cases of toxoplasmosis, however, samples originating from the vicinity of humans may be 
optimal, thus overestimating their number, if the infection affects the behavior of animals 
that would normally avoid humans. Infection might predispose them to being killed by 
hunting or in a traffic accident. These cases may also represent the sentinels of pathogen 
spillover from or into domestic circles, and the parasite strains humans could become 
infected with as well. 
6.1.3. Methodology 
The serology method (DAT) has been validated for human sera only. Nevertheless, DAT 
and its in-house version, the modified agglutination test (MAT), have both been widely 
used for screening the sera of different animals species (European Food Safety Authority 
EFSA, 2007; Dubey, 2010), and bodily fluids when sera are unavailable (Tryland et al., 
2006; Ryser-Degiorgis et al., 2006; Jakubek et al., 2012), for anti-Toxoplasma gondii IgG 
antibodies. We chose the commercial DAT rather than an in-house version for these 
studies in order to obtain more accurate comparability of the results.  
 
One major advantage of DAT is that it requires no species-specific reagents. The most 
important reagents are the antigen (formalin-treated parasites) and 2-ME that denatures 
IgM (Pike and Chandler, 1972; Johnson et al., 1989). Preservatives other than formalin 
have also been used for antigen preparation (Oksanen et al., 1996; Montoya et al., 2007; 
Dubey, 2010). According to the manufacturer, DAT specifically detects only one antibody 
class: IgG. These antibodies are relevant for epidemiological studies, because they are 
specific and presumably long-lasting (Dubey, 2010). However, results contradicting this 
assumption have emerged: the persistence of antibodies may be related to the host species 
or to other factors (Opsteegh et al., 2011a; Opsteegh et al., 2011b; Fernandez-Aguilar et 
al., 2013). Moreover, negative DAT results indicate the absence of a detectable level of 
IgG antibodies, but do not rule out other types of immune response. 
 
The manufacturer suggests using two dilutions (1:40 and 1:4000), with 1:40 serving as the 
cut-off for positivity. We chose to use only one dilution for most of the samples due to the 
cost of the kits and the little extra benefit expected from two dilutions. Some false 
negative results were expected due to the prozone phenomenon. In the cat study (V), the 
prozone phenomenon was observed in 1.3% of the samples: 6 of the 445 samples diluted 
to both 1:40 and 1:4000 yielded a negative result at 1:40 and a seemingly paradoxical 
positive result at 1:4000. This prozone phenomenon occurs due to an excessively high 
concentration of antibodies in relation to the antigen for agglutination to occur; few or no 
antibodies bind more than one antigenic particle, forming a bridge between them. As a 
result, the observed result at too low a dilution is a false-negative, and positivity is seen 
ony when the sample is sufficiently diluted. 
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The samples that tested positive at a dilution of 1:40 or 1:4000 (the samples exhibiting the 
prozone phenomenon detected by using two dilutions) or both were defined as 
seropositive. This threshold for seropositivity is the one recommended by the 
manufacturer and the one used in several studies with which we wanted our results to be 
comparable (Näreaho et al., 1995; Oksanen and Lindgren, 1995; Oksanen et al., 1997; 
Saarhelo, 1998; Vikøren et al., 2004; Ryser-Degiorgis et al., 2006). Many other studies 
use a lower titer (reciprocal of the highest dilution that yields a positive result), such as 16 
or 25, as the cut-off, so our 40 is high in comparison (Gamarra et al., 2008; Dubey, 2009b; 
Dubey, 2009c; Dubey, 2010). Thus, our estimates of seroprevalences can be considered 
conservative. 
 
The reading of the DAT results is simple and fast. We used a four-point scale to record the 
results for initial comparison and evaluation, and a dichotomous interpretation as the final 
result. The instructions of the manufacturer state that a positive reaction is “a mat covering 
about half of the well base” and the shrinking of its borders is acceptable, whereas all 
smaller mats are borderline reactions. In our interpretation, the mat was evaluated as 
covering at least half of the bottom of the well (interpreted as positive) or less than half of 
the bottom of the well (interpreted as negative). Our interpretation may in certain 
individual cases be stricter than the manufacturer’s recommendation, further making our 
estimates conservative.  
 
According to the manufacturer, the sensitivity of DAT is 96.2% (95% CI 94.55-97.39) and 
its specificity is 98.8% (95% CI 96.46-99.60) compared with the dye test, which is 
considered the gold-standard in human serology. The sensitivity and specificity of this 
method for use in different animal species is largely unknown. A recent study showed that 
ELISA and MAT did not differ significantly when used to detect T. gondii antibodies in 
cats (Zhu et al., 2012). The manufacturer of DAT also reports high precision when 
retesting the same samples in the same and different runs, and by different operators: the 
maximum deviation observed was a difference of one dilution within the recommended 10 
dilutions. The positive predictive value of this test in a population with low 
seroprevalence, however, is only moderate (Sukthana et al., 2001). Using a high cut-off 
and explicit criteria for defining a sample as positive minimized this problem. 
 
Hemolysis was not expected to affect the results obtained even though the method has not 
been validated for hemolyzed sera. The manufacturer recommends collecting a new 
sample in case of a hemolyzed sample, which is impossible from wildlife sampled by 
hunters. It has been noted that hemolysis would not affect the results of DAT/MAT 
(Dubey, 2010), but no studies have earlier confirmed this. We found no effect on the DAT 
results when testing samples hemolyzed in a variety of ways, whereas clarifying the 
samples with Hemoglobind (Biotech Support Group) prior to testing yielded false-
negative results.  
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Sera are naturally better material for serology than tissue fluid samples, but obtaining high 
numbers of good quality serum samples from wildlife is challenging. Body fluids, such as 
serosanguineous fluid collected from the heart or thoracic cavity, are often used (Ferroglio 
et al., 2000; Ryser-Degiorgis et al., 2006; Jakubek et al., 2012). The seroprevalence 
estimates obtained from such material are likely underestimates due to lower antibody 
levels than in serum, and postmortem sampling (Ferroglio et al., 2000; Tryland et al., 
2006; Jakubek et al., 2012).  
 
The method used for oocyst detection, FLOTAC, is sensitive and has minimal background 
visibility blocking problems because the top portion of the flotation solution is transferred 
aside before microscopy. This also allowed for easy collection of the top portion for the 
necessary PCR confirmation of the T. gondii-like oocysts detected as well as for their 
further characterization (V). 
 
More detailed clinical data were available from only some of the cats (V); clinical 
chemistry and hematological parameters, for example, were examined in only four of the 
six cats. Comparing detailed clinical data with postmortem findings in a larger number of 
toxoplasmosis cases would be of veterinary relevance: toxoplasmosis is a challenging 
clinical diagnosis, but should be on the differential diagnosis list, especially for young cats 
with acute pneumonia and hepatitis (V).  
 
Diagnosing toxoplasmosis postmortem can be challenging as well, due mainly to 
unspecific gross findings. In a Swedish study, several previously missed toxoplasmosis 
cases were found in hares retrospectively by using IHC (Gustafsson et al., 1988). IHC has 
been shown to be a good method for evaluating the spread and burden of parasites in 
tissues (Uggla et al., 1987; Gustafsson et al., 1988), a finding that our studies (III, IV, V) 
also confirmed. Without this technique, the spread and numbers of parasites would have 
been greatly underestimated. 
 
Isolating T. gondii strains directly into cell cultures is simple, but requires aseptically 
collected samples. A positive result can be detected faster than with bioassay in mice or 
cats (Derouin et al., 1989; Miller et al., 2000).  
 
For the molecular methods, the DNA concentrations of the DNA extracts were not 
routinely measured. The methods were not quantitative, and the samples were not 
uniform. The possibility of false negatives was accepted, and the sensitivity of the 
molecular methods has not been determined in detail. In these studies, the molecular 
methods served for confirmation and for further characterization. Specific DNA was 
successfully amplified from many sample types, including various FFPE and frozen 
tissues, feces, and cell culture samples. All these were rich in parasites by microscopy. 
 
The parasites may be unevenly distributed in the sample, so even a sensitive method may 
fail to detect the parasites or their DNA. In these studies, flotation methods served as pre-
enrichment methods for fecal samples and centrifugations for cell culture samples. More 
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simple methods for enriching the parasites from various sample types (e.g. meat, milk, 
semen, feces, and soil) would broaden the reseach possibilities. 
 
Six MS markers for genotyping appeared to be enough for these studies, and the seventh 
fingerprinting marker proved valuable in providing further characterization (Table 7). 
Genotyping with fewer than four or five markers should be interpreted cautiously because 
more markers could reveal more polymorphisms (Ajzenberg, 2010; Subauste et al., 2011). 
The updated version of the MS genotyping method (Ajzenberg et al., 2010), with its 15 
MS markers, would be an effective tool for investigating outbreaks.  
 
The MS genotyping method yielded consistent results from different samples from the 
same individuals (IV, V), and the analysis almost always proved successful at all markers 
(Table 7), even if its sensitivity is lower than that of methods based on nested-PCR 
(Ajzenberg et al., 2010). We also tested a nested-PCR-RFLP-method for genotyping 
(Howe et al., 1997; Khan et al., 2005; Dubey et al., 2006; Su et al., 2006), but the results 
were occasionally inconsistent and showed low reproducibility even from reference 
material. The genotyping method as well as the number of markers used for genotyping 
are relevant in evaluating any genotyping results. The combined use of several methods is 
optimal in investigating genetic diversity (Su et al., 2012). 
 
In these studies (III, IV, V), the parasites present in the sample material were characterized 
directly, without a bioassay step that could have had a selective effect. This is another 
relevant point to consider when evaluating genotyping results. For example, mixed 
infections with more than one strain might be missed if isolation into cell cultures or 
especially bioassay in laboratory animals were performed first.  
 
Formalin fixation adversely affects PCR amplification (Ben-Ezra et al., 1991), but the 
genetic analysis of T. gondii was also successful from DNA extracted from archived FFPE 
material (III, IV, Table 7). It is thus possible to re-investigate old cases with new 
molecular methods, to carry out retrospective molecular epidemiological studies, and to 
utilize the practical storage and transport as FFPE samples in long-term prospective 
studies. 
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6.2. Major findings and their relevance 
6.2.1. Exposure to Toxoplasma gondii is common  
Of all the host species examined, some animals had mounted a detectable IgG antibody 
response against T. gondii. The infections were naturally acquired, most likely within 
Finland: T. gondii is endemic. Wild animals do not respect international borders, and the 
estimates can be regarded as estimates of the area. Some domestic cats could have 
encountered the parasite during travels or via imported feed. 
 
Based on the serology results, the animals intended for human consumption had 
commonly encountered T. gondii. The seroprevalence in sheep (24.6%; I) was similar to 
previously reported estimates from Scandinavia and elsewhere (Lundén et al., 1992; 
Skjerve et al., 1998; Dubey, 2009c). The seroprevalence in moose (9.6%; I) was lower 
than estimates of 12.6% from Norway (P < 0.01) and 20.4% from Sweden (P < 0.0001), 
which were obtained with the same method and used the same cut-off for seropositivity as 
we did (Vikøren et al., 2004). The seroprevalence in white-tailed deer (26.7%; I) was 
higher than the overall seroprevalence in moose (P < 0.0001), but the difference was 
nonsignificant in comparison to moose originating from the same southwestern game 
management districts where the deer were sampled. Interestingly, the seroprevalence in 
white-tailed deer was lower than the estimates of 30.0-64.2% reported in the United States 
(Lindsay et al., 1991; Vanek et al., 1996; Dubey, 2010), which were obtained using MAT 
and 1:25 or 1:50 as the cut-off for seropositivity. Despite a higher cut-off for defining a 
sample as seropositive, the T. gondii seroprevalence in Finnish farmed wild boars (33.0%; 
II) was seven times higher than that in captive wild boars in Brazil (Fornazari et al., 2009). 
The seroprevalence in Finnish farmed wild boars was also higher than an ELISA-derived 
seroprevalence (20.3%; P <0.05) in Latvian farmed wild boars (Deksne and Kirjusina, 
2013). The free-ranging wild boars of Estonia had a lower seroprevalence (24.0%; P 
<0.05) with the same method and cut-off we used (Velström et al., 2013), whereas ELISA 
yielded a seroprevalence similar to ours (35.1%) in free-ranging wild boars in Latvia 
(Deksne and Kirjusina, 2013).  
 
All the seropositive brown hares died of the T. gondii infection, whereas no seropositives 
were detected among the hares that had died of other causes (III). In contrast, a 
seroprevalence of 4.2% (4/96) was found among mountain hares that had succumbed to 
causes other than toxoplasmosis (III). If the latter results are true positives, these animals 
might have had a mild, chronic infection without parasites in the organs examined. 
Chronic infections thus appeared to be relatively rare to nonexistent among hares, while 
toxoplasmosis is confirmed to be a common infectious cause of death in both species of 
hare (III). This observation is similar to those of Swedish studies from the 1980s; 
toxoplasmosis was the cause of death in 10% of brown hares and 4% of mountain hares, 
while no seropositives were found among 176 apparently healthy brown hares despite the 
use of several serology methods (Gustafsson et al., 1988; Gustafsson and Uggla, 1994). 
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Together, these Nordic findings strongly support the hypothesis that these species of hare 
are highly susceptible to severe clinical toxoplasmosis. However, other studies have 
identified more seropositive hares, leaving the hypothesis debatable (Valtonen and 
Andersson, 1968; Hejlicek et al., 1997; Frölich et al., 2003; Aubert et al., 2010). Of note, 
very recent observations suggest that antibodies might not persist in some species of hare, 
making this question even more intriguing (Fernandez-Aguilar et al., 2013). On the other 
hand, experimental studies have also demonstrated toxoplasmosis to be a severe and fatal 
infection among hares (Gustafsson et al., 1997a; Gustafsson et al., 1997b; Sedlak et al., 
2000). 
 
Almost half the domestic cats (V) and a majority of the lynx (VI) had antibodies against T. 
gondii. The seroprevalence in lynx can be considered an underestimate, since it was 
obtained from serosanguineus fluid that likely contained lower antibody levels than serum 
(Ferroglio et al., 2000; Jakubek et al., 2012).  
 
In domestic cats, the seroprevalence had not changed from the previous estimate (Näreaho 
et al., 1995; Näreaho, 1995) obtained with the same method and cut-off for seropositivity 
– but from shelter cats only, whereas ours is mainly from pedigreed, purebred pets. In 
contrast, the seroprevalence in lynx was significantly higher than the previous estimates 
from Finland and Sweden, which also used the same method and cut-off (Oksanen and 
Lindgren, 1995; Ryser-Degiorgis et al., 2006). The proportion of samples from young 
animals and of samples from the northern parts of the countries may partly explain the 
difference between the Swedish estimate and ours. Nevertheless, the lynx population of 
Finland has more than doubled since those estimates (Finnish Game and Fisheries 
Research Institute, 2008), and more lynx could now be exposed to possible pathogen 
spillover to and from domestic animals (Power and Mitchell, 2004).  
 
The north-south gradient in the evidence of exposure to T. gondii was present in a wild 
and a domestic herbivore, a farmed omnivore, and a wild, free-ranging carnivore (I, II, III, 
IV, VI), thus exemplifying the importance of a sampling plan that geographically covers 
the area of interest. A similar gradient has been observed previously in Finland in 
reindeer: the highest T. gondii seroprevalences were detected in the southernmost herding 
districts and were attributed to corral feeding, which leads to more contact with domestic 
cats (Oksanen et al., 1997). Several other studies have also reported geographical 
differences in T. gondii seroprevalences (Uggla and Hjort, 1984; Vikøren et al., 2004; 
Ryser-Degiorgis et al., 2006; Malmsten et al., 2011; Beral et al., 2012), and infection 
kinetics over the lifetime of animals may also differ by region (Halos et al., 2010). 
 
Climatic factors may partly explain the geographical gradients. The northern temperate 
climate and mean annual temperature of 5.5 °C in southern Finland certainly differs from 
the subarctic climate and below zero mean temperature of the north (Finnish 
Meteorological Institute, 2013). Herbivorous animals, such as moose, sheep, and hares 
most likely encounter T. gondii via oocysts in their feed or water (Skjerve et al., 1998; 
Tenter et al., 2000; Kijlstra and Jongert, 2008). The harsh northern winters may affect 
 
 
 
 
79 
sporulation, but likely not the survival of sporulated oocysts (Frenkel and Dubey, 1973; 
Hill and Dubey, 2002; European Food Safety Authority EFSA, 2007; Dubey, 2010). A 
more likely explanation is the concentration of the human population in the southern and 
southwestern parts of Finland, with its domestic cats. Moreover, our findings (III, IV) as 
well as others’ (Hülphers et al., 1947; Christiansen and Siim, 1951) indirectly confirm the 
survival of oocysts: hosts that likely become infected from oocysts died of acute 
toxoplasmosis in the winter. However, carnivorism may also be possible in these hosts. 
Squirrels are omnivorous, and evidence suggests that herbivorous hares might sometimes 
eat the tissues of other animals (Rausch et al., 1956). Overall higher host population 
density might be another local explanatory factor, similarly to Trichinella spp. infections 
transmitted by carnivorism and scavenging (Airas et al., 2010). For the lynx in particular, 
the main prey species in the south differ from those in the north, which may partly explain 
the gradient (VI). 
 
Geographical variation in the prevalence of T. gondii infection is relevant for risk 
assessment and recommendations. Seropositive animals have at least encountered the 
parasite and can therefore be considered sentinels, indicating that humans may also 
encounter the parasite in these same areas. Seropositivity correlates with the chronic 
presence of T. gondii in many hosts (Lindsay et al., 1991; Richomme et al., 2009; Halos et 
al., 2010), but not well in others (Opsteegh et al., 2011b). Animals carrying T. gondii may 
pose a risk for human infection when humans handle their carcasses (Sacks et al., 1983; 
McDonald et al., 1990; Ross et al., 2001; Vikøren et al., 2004) or eat their insufficiently 
cooked meat (Cook et al., 2000). The meat of hunter-harvested wildlife is mainly 
consumed locally. Privately consumed game is not subject to meat inspection, and the 
current inspection does not even attempt to detect T. gondii infections. 
 
Seropositive animals were found throughout Finland, including the northern regions, thus 
showing that cold climate and remote locations pose no barrier to this parasite. The hosts 
of T. gondii, undoubtedly including humans, may encounter the parasite even in the 
northernmost parts of Europe. 
6.2.2. Risk factors and actions 
As expected, the seroprevalences were higher in older animals (I, II, V, VI) with a longer 
time during which to encounter the parasite. The hosts investigated typically appeared to 
have encountered the parasite after birth, as an acquired infection. No signs of antibody 
waning were noted. Toxoplasma gondii infections were common, especially in the 
southern part of Finland (I, II, III, IV, VI).  
 
The risk analysis of feline infections identified several important points for cat owners to 
consider (V). Cats typically become infected by ingesting raw meat, either in the form of 
prey they catch or meat their owners feed to them. Raw meat was part of the diet of 78.4% 
of the cats (V) and a major risk factor for seropositivity. Cats do need meat in their diet, 
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but should receive it after sufficient cooking or at least freezing to avoid T. gondii 
infection. Allowing cats to roam outdoors freely gives them opportunities not only to hunt 
infected animals, but also to defecate in the environment – both to become infected and to 
spread the infection causing risk to other hosts. Access outdoors was common and a risk 
factor for seropositivity even though it did not fit the final multivariable models (V). Cats 
that have opportunities to become infected and then to defecate into the environment may 
contribute to the oocyst burden of the environment.  
 
The observed differences between seroprevalences in different cat breeds (V) were also 
likely associated with their lifestyles: over 80% of Birmans, a breed with the highest 
seroprevalence (65.3%), received raw meat in their diets and roamed outdoors. Korats had 
a significantly lower seroprevalence (40.2%), and fewer than half of them received raw 
meat in their diets, and 80% were kept exclusively indoors.  
 
Cat owners could do more to protect their pets from encountering T. gondii, as well as to 
ensure that their cats do not fall ill from it or spread it. Furthermore, the infection was 
associated with reproduction problems (V), which are of particular concern to cat 
breeders. No vaccine is currently commercially available, yet the known risk factors are 
the points where preventive action could be taken (Elmore et al., 2010; Dabritz and 
Conrad, 2010; Opsteegh et al., 2012). 
 
Proper disposal of cat litter, whether in communal waste or by burning, hampers the 
spread of the parasite from infected cats (Dabritz and Conrad, 2010). The feces of 
domestic cats should not be disposed of via toilets, as T. gondii oocysts are not destroyed 
by chemical and physical sewage water treatments even at levels up to six times higher 
than routinely used for raw sewage (Wainwright et al., 2007a; Wainwright et al., 2007b). 
Because of this, the manufacturers of cat litter in California advise against flushing cat 
feces down toilets (Dabritz and Conrad, 2010). 
 
For the parasite, the environmental reservoir of oocysts is an important source of infection 
for many hosts, including domestic and game animals intended for human consumption. 
Interestingly, it is often referred to as contamination instead of a reservoir (McAllister, 
2005; Robert-Gangneux and Dardé, 2012). Human actions that allow or even enhance the 
shedding of the oocysts into the environment by the definitive hosts kept as pets can be 
considered contamination of the environment. 
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6.2.3. Domestic cats have the major definitive host role in Finland 
When discussing the environmental oocyst burden in 2010 (I), placing the blame on 
domestic cats for contaminating the environment while describing the contribution of the 
local wild felids as “unknown” felt only partly reasoned. Speculations about the 
importance of lynx were based on limited data (Oksanen and Lindgren, 1995) showing 
that lynx commonly encounter the parasite. The shedding of T. gondii oocysts by this lynx 
species has never actually been reported (Ryser-Degiorgis et al., 2006; Dubey, 2009a).  
 
Our serology results indicate that both cats and lynx often encounter T. gondii in Finland 
(V, VI). Using the same method and cut-off, the seroprevalence in lynx (86.1%) was 
significantly higher than that in cats (48.4%; P < 0.0001). The seroprevalence estimate in 
lynx may be an underestimate due to the available sample material, which consisted of 
serosanguineus fluid samples collected postmortem instead of sera (Ferroglio et al., 2000; 
Tryland et al., 2006; Jakubek et al., 2012).  
 
Infection was more common in lynx than before (Oksanen and Lindgren, 1995; Ryser-
Degiorgis et al., 2006), and ever common in cats (Näreaho, 1995; Näreaho et al., 1995). 
The proportional mortality rate from toxoplasmosis in cats (V) did not differ significantly 
from a Danish estimate (Henriksen et al., 1994).  
 
The odds of seropositivity in cats increased with age (V) and in lynx, with weight gained 
(VI). Older lynx are likely heavier, but males are almost always heavier than females of 
the same age. In the multivariable models, which included weight and sex, weight can be 
cautiously interpreted to represent age, as sexual dimorphism was accounted for by 
including the sex of each animal in the models (VI).  
 
One cat was confirmed to be contributing to the environmental oocyst burden by shedding 
oocysts of the endemic genotype II (V). In contrast, no T. gondii-like oocysts were 
detected in the fecal samples from the lynx (VI). Seropositive domestic cats are regarded 
as cats that have previously shed oocysts (Dubey, 2010), and most of the lynx examined 
were seropositive (VI). Similarily to cats (Dabritz and Conrad, 2010), the shedding of 
oocysts by lynx might occur mainly soon after primary infection. However, this 
extrapolated assumption was not supported by the experimental infection of a lynx: no 
shedding was detectable despite seroconversion (Oksanen et al., 1997). Moreover, only a 
small proportion of the population of domestic cats sheds oocysts at any given moment 
(Dabritz and Conrad, 2010), as this study (V) also showed. The shedding of oocysts lasts 
for a limited period and for most cats occurs only once (Dabritz and Conrad, 2010; Dubey, 
2010). Obtaining a sample size of lynx sufficient to find shedders can be challenging. Our 
study and a Swedish one (Ryser-Degiorgis et al., 2006) investigated fecal samples from 
altogether 68 young lynx, 34 of which tested seronegative, and detected no shedding. 
Sampling younger lynx might be the way to show that lynx do indeed shed oocysts after 
naturally acquired infection or to confirm that they do not.  
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If lynx do not shed oocysts, their role in the epidemiology of T. gondii is limited to that of 
infected individuals that are eaten by other hosts, mainly scavengers, and an unknown 
contribution through other infection routes. The human consumption of lynx meat is not 
unknown in Finland, and carcass handling might pose another gateway to humans (Sacks 
et al., 1983; McDonald et al., 1990; Ross et al., 2001; Vikøren et al., 2004). Cats are only 
rarely eaten by predators (including lynx) in Finland, so they serve almost exclusively as a 
source of oocysts.  
 
Domestic cats, with a population of approximately 800 000, clearly outnumber the fewer 
than 3000 lynx, and thus play the major definitive host role in the epidemiology of T. 
gondii in Finland. Preventing the infections of pet animals is far easier than applying 
preventive measures to free-ranging, protected wildlife.  
6.2.4. No signs of separate domestic and sylvatic cycles 
Wildlife, semidomesticated, domestic and pet animals, and humans can encounter T. 
gondii in Finland. This has been shown by serological methods in these studies (I, II, III, 
V, VI) and previous ones (Valtonen and Andersson, 1968; Lappalainen et al., 1992; 
Hirvelä-Koski, 1992; Nieminen, 1993; Oksanen and Lindgren, 1995; Näreaho, 1995; 
Näreaho et al., 1995; Oksanen et al., 1997; Saarhelo, 1998). Moreover, T. gondii strains 
belonging to the endemic genotype II have now been shown to be an occasional cause of 
death of both wild and domestic hosts (III, IV, V; Table 7), and one domestic cat was also 
shown to shed parasites of this genotype. This same genotype infecting both wild and 
domestic animals suggests that the infections in the two host groups do not follow separate 
cycles.  
 
Free-ranging wild animals are part of the host range of T. gondii in Finland and contribute 
to its success. Because numerous host species eat each other, wild hosts are unlikely to be 
dead-end hosts. Carnivorism and scavenging in a suitable host density ensures the parasite 
a steady supply of new hosts. Although by no means the only way, humans may become 
infected when eating undercooked meat or handing the carcasses of infected game. 
Domestic cats may become infected by eating small wildlife prey. If the lynx shed 
oocysts, they may provide a source of infection for other hosts, including domestic 
animals. Wildlife in the southern part of Finland, where the human population is 
concentrated, appears to be infected more often than the wildlife in the north. This 
suggests that domestic cats living with humans play a crucial role in the epidemiology of 
T. gondii by shedding oocysts that serve as a source of infection for both wild and 
domestic hosts. Among the wildlife, obvious victims of this spillover, such as brown hares 
and mountain hares (III), and possibly red squirrels (IV), often die from the infection. 
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6.2.5. Some hosts appear to be highly susceptible to severe clinical toxoplasmosis 
Our results (III) support the hypothesis that brown hares and mountain hares are extremely 
susceptible to death from toxoplasmosis. Toxoplasmosis was confirmed as a common 
infectious cause of death for both hare species, and all the brown hares that encountered T. 
gondii and mounted a measurable antibody response against it died of it. These infections 
were naturally acquired; the infective stage of the parasite causing the infection, the 
infection dose, and the infection route were likely ones to which these animals are “best” 
adapted. The parasite strains that caused the deaths were all of genotype II, which is 
generally considered a genotype of low virulence and causing mainly chronic, subclinical 
infections. 
 
The Swedish studies (Gustafsson et al., 1988; Gustafsson and Uggla, 1994; Gustafsson et 
al., 1997a; Gustafsson et al., 1997b) reached a similar conclusion: zero prevalence of 
antibodies, a common cause of death, extensive tissue damage after experimental 
infection, and the lack of a proper cellular response. The parasites used in the experimental 
infections were reportedly of low virulence in mice, but the genotype of the strain used is 
unknown. Overall, limited data have been available on the characterization of T. gondii 
strains that cause fatal disease in hares. An Italian isolate caused chronic infection when 
inoculated into mice (Olliaro et al., 1993), whereas Danish and Japanese isolates were as 
highly virulent in mice as the genotype I strain RH (Christiansen and Siim, 1951; Shimizu, 
1958; Shimizu and Takagaki, 1959). 
 
Red squirrels might also be a host species that is very susceptible to severe, clinical 
toxoplasmosis, even when infected with parasite strains of low virulence to other hosts. 
Despite the very limited sample size, the proportional mortality rate in our study was high, 
and the three fatal cases were all caused by T. gondii strains of genotype II (IV). Similar 
observations have been reported in squirrels kept in a zoo: the parasites that caused three 
deaths caused chronic infection when inoculated into mice, but killed an inoculated red 
squirrel within eight days (Rodhain, 1950). The genotype of those parasites is unknown, 
but their virulence in mice resembled that of genotype II. 
 
The hosts that are highly susceptible to death from this common parasitic infection should 
be protected from it when possible. Investigating the infections in these hosts in detail 
could reveal key information and deepen our understanding of the parasite-host interaction 
and the factors affecting the outcome of the infections. At least in these cases, the deaths 
cannot be attributed to a particularly virulent causative strain, and no immunosuppression 
was evident either. 
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6.2.6. Underestimated genotype II can kill 
All the T. gondii strains that had killed the hosts in our studies belonged to genotype II, 
and the genetic diversity was low (III, IV, V, Table 7). These infections were naturally 
acquired and thus support the endemic presence and dominant status of this genotype in 
Europe – and now confirmedly in Finland also. Thus far, strains belonging to other 
genotypes have not been detected in Finland.  
 
The result seems surprising because genotype II strains typically cause only subclinical, 
chronic infections in immunocompetent hosts and are thus considered nonvirulent 
(Maubon et al., 2008). Recently, however, genotype II strains have also been found to 
cause death in a variety of host species elsewhere in Europe (Prestrud et al., 2008; Spycher 
et al., 2011; Herrmann et al., 2013). The victims were arctic foxes, a cat, and a beaver; 
ours included brown hares, mountain hares, red squirrels, and cats (III, IV, V). None of 
these altogether 33 animals had apparent signs of immunodeficiency or any concurrent, 
possibly predisposing disease. The infections were naturally acquired, so the infective 
stages of the parasite, infection doses, and infection routes were likely nothing out of the 
ordinary natural environment, but something to which these hosts should be adapted.  
 
Genetic characterization of the parasite strains that cause severe and even fatal 
toxoplasmosis in different host species helps to deepen our understanding of one of the 
major current topics in toxoplasmosis research: evaluating the effect of the genotype of the 
parasite on the outcome of infection. Too little is known of T. gondii genotype distribution 
and effect in the infections of animal hosts: such data could provide relevant insight into 
this interesting topic in human medical parasitology (Ajzenberg et al., 2002; Ajzenberg et 
al., 2009; Subauste et al., 2011; Fekkar et al., 2011; Carneiro et al., 2013). Animal hosts 
outnumber human hosts, which permits the collection of more data with reasonable time 
and effort. Moreover, animals can be regarded as sentinels for the T. gondii strains present 
in an area. The strains the animals harbor and the possibly more virulent strains that cause 
disease in the animal hosts are the ones humans may encounter as well, so their 
characterization is also relevant from the perspective of public health. 
 
Genotype II T. gondii parasites should not be underestimated, as natural infections with 
strains belonging to this genotype can be fatal. The endemic, common presence of 
parasites of this potentially dangerous genotype in the environment and in animal hosts is 
both a risk factor and a welfare issue for them as well as for other hosts, including 
humans.  
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7. Conclusions 
Toxoplasma gondii thrives in Finland. It is both common and endemic, has infected a wide 
variety of host species, and is shed into the environment. 
 
Toxoplasma gondii appears to have no separate domestic and sylvatic cycles in Finland. 
Strains belonging to genotype II were found infecting both domestic and wild hosts, and 
the genetic diversity was low. 
 
Toxoplasma gondii genotype II is thus endemic in Finland. The virulence of T. gondii 
strains of this genotype should not be underestimated. Such strains had killed six cats, 
fourteen brown hares, four mountain hares, and three squirrels.  
 
Known risk factors for T. gondii infections show where preventive measures could prove 
most effective. Domestic cats in particular should be better protected from encountering 
this parasite. 
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